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ABSTRACT 
The synthesis of the pineal hormone, melatonin, is finely regulated by the pineal enzyme 
serotonin N-acetyltransferase (NAT). In the absence of light, the activity of NAT is markedly 
enhanced by the release of nor-adrenaline from sympathetic nerve endings in the pineal. 
Exposure of animals to light during darkness causes a sudden and dramatic reduction in the 
activity of NAT. 
The present study investigated a possible mechanismfor this sudden decline in NAT activity. 
These investigations included the determination of the effects of S-adenosylmethionine (SAM), 
adenosine nucleotides and calcium on NAT activity. 
In vitro experiments using SAM showed that pineals pre-incubated with SAM prior to 
adrenergic stimulation did not significantly alter NAT activity or pineal indoleamine 
metabolism. However, measurement of pineal cyclic AMP showed that SAM exposure 
reduced the adrenergic-induced rise in pineal cyclic AMP. 
Experiments using adenosine 5 '-monophosphate (5 '-AMP) showed that this nucleotide 
enhanced both dark- and isoproterenol-induced NAT activity. Adenosine 5 '-triphosphate 
(A TP), on the other hand, reduced NAT activity with a concomitant reduction in pineal 
indoleamine metabolism. Exposure of isoproterenol-stimulated pineals in organ culture to 
propranolol resulted in a marked rise in ATP and adenosine 5 '-diphosphate (ADP) synthesis 
accompanied by a decline in 5 '-AMP levels as compared with pineals treated with 
isoproterenol alone. This then implies that exposure of animals to light could cause a change 
in pineal nucleotide levels. 
Since nucleotide levels are also controlled by calcium, experiments were carried out to 
determine the effect of calcium on pineal NAT activity. These experiments showed that 
ethyleneglycol-bis-N,N,N,N,-tetraacetic acid (EGTA) enhanced NAT activity whilst calcium 
reduced the activity in pineal homogenates, implying that calcium may act directly on NAT 
to regulate its activity. Exposure of pineal glands in organ culture to the calmodulin 
antagonist R24571 caused a rise in pineal cyclic AMP levels with a concomitant decrease in 
iii 
cAMP-phosphodiesterase activity. This was, however, accompanied by a decline in N-
acetyl serotonin and melatonin synthesis. 
These findings implicate a number of factors in the regulation of pineal NAT activity. A 
mechanism for the regulation of pineal NAT is proposed. 
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1.1 Pineal History 
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CHAPTER I 
LITERATURE REVIEW 
The human pineal gland was fIrst discovered by Herophilos (325 - 280 BC) a famous 
anatomist at the University of Alexandria in Egypt (Ariens-Kappers, 1979). He took the 
pineal to be a "tap" which regulated the stream of pneuma (the human spirit) from the third 
to the fourth ventricles of the brain. 
Galen (130 - 300 AD) took the pineal to be a gland like any other. He coined the term soma 
konoeides for the pineal because, in man, the pineal is shaped like the cone of a pine tree. 
Berenganio da Capri (1470 - 1530) was the fIrst to examine the human pineal gland in more 
detail. Rene Descartes (1596 - 1650) described the pineal as the "seat of the soul". This 
statement came at a time in history when the soul was of importance to scientists and 
philosophers alike. This theory of the "soul" and other superstitions lasted for many centuries 
(Ariens-Kappers, 1979). 
It was in the second half of the nineteenth century that a renewed interest in the anatomy, 
histology and embryology of the pineal gland took place. Factors promoting this interest 
were new techniques in the sectioning and staining of slides (Ariens-Kappers, 1979). 
The discoveries of the endocrine glands and hormone producing organs by Bernard (1813 -
1878) and Brown-Sequard (1817 - 1894) greatly stimulated the interest of physiologists in the 
pineal gland. It was at the end of the nineteenth century that the mammalian pineal was fIrst 
considered as a serious candidate for hormonal production (Ariens-Kappers, 1979). Later, 
Berlinger (1920) and Engel (1936) proposed that the pineal gland had an inhibitory effect on 
gonadal development. These views were later criticized when the structure and function of 
the hypothalamus became better known (Ariens-Kappers, 1979). 
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In 1943 a landmark in pineal research was reached by Bargmann. This author published a 
survey on the microscopic anatomy, histology and cytology of the pineal gland, from fish to 
man. A further survey in 1954 by Kitay and Altschule, of all previous data on pineal 
physiology, initiated a steady interest in pineal research which has progressed to the present 
time. 
1.2 Pineal Anatomy 
1.2.1 Location 
In the rat, the pineal gland is situated in the superior part of the sulcus transversus cerebri 
at the surface of the brain between the hemispheres anteriorly and the cerebellum posteriorly 
(Kappers, 1960). The pineal gland is connected to the commissural region by a thin filament-
like stalk. This pineal stalk is formed by the fusing and growing out of the anterior and 
posterior epiphyseal peduncles originating from the most proximal parts of the rostro-dorsal 
and caudo-ventral walls of the original epiphyseal evaginations (Kappers, 1960) (Figure 1.1). 
The pineal stalk may be divided into three distinct parts, viz. a proximal part, a midpart and 
a distal part. The proximal part lies between the habenular and caudal commissures. The 
midpart is often extremely thin. The distal part is the largest of the three structures and is 
situated between the rostral and caudal collicles (Kappers, 1960). 
1.2.2 Blood Supply 
In 1940, Gladstone and Wakely found that the major blood supply to the pineal gland was 
provided by the posterior choroidal arteries. The posterior cerebral arteries also branch into 
the pineal gland to form a capillary network. Blood is drained from the pineal via 12 - 16 
superficial connecting veins. These veins lead into the distal end of the great cerebral vein, 
which ultimately leads the blood into the systemic venous system (Hodde, 1979). The blood 
supply reaches the pineal gland at a rate of flow surpassed only by the kidney, and is greater 
at night than during the day (Quay, 1972; Rollag, 1988; Reiter, 1981). 
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FIGURE 1.1 Transverse section o/the rat brain showing the relative position o/the pineal 
body and pineal stalk (Rowett, 1962). 
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1.2.3 Pineal Innervation 
The pineal gland of mammals is heavily innervated by nor-adrenaline-containing sympathetic 
fibres (Pfister et al., 1978; Ronnekleiv and Moller, 1978; Semm, 1978) located in the 
perivascular space and in the parenchyma between the pinealocytes (Matsushima et al., 1981). 
The perikarya of these sympathetic fibres are located in the superior cervical ganglion, from 
which the fibres reach the pineal via the conarian nerves (Kappers, 1960). The secretory 
function of the mammalian pineal gland has been linked to its sympathetic innervation (Wolfe 
et al., 1962). 
The parasympathetic system is found together with the sympathetic system (Kenny, 1961; 
Romijn, 1975). The function of the parasympathetic nervous system in the pineal needs 
further investigation. The terminals of both these systems do not form synapses with the 
pinealocytes (Kappers, 1976), but end in the perivascular space where the neurotransmitter 
diffuses to receptors on the pinealocyte surface. 
Aberrant commissural fibres of the habenular commissure have been shown to form hairpin 
loops in the pineal stalk (Kappers, 1960). Reiter (1982) suggests that stimuli from other 
parts of the central nervous system (eNS) may pass near to the habenular nucleus and may 
thereby influence its function. This suggests that pineal function may not exclusively depend 
on stimuli of various origins reaching the gland via its sympathetic innervation. 
The pineal gland is often referred to as the "neuro-endocrine transducer organ" by virtue of 
its ability to synthesise and release melatonin in response to a neuronal input. An external 
light stimulus is converted to photic signals in the retina. These signals pass via the 
suprachiasmatic nucleus, to the tubural hypothalamus, over the medial forebrain bundle, 
reticula formation and upper thoracic intermediolateral cell column, to the superior cervical 
ganglion whose post ganglionic sympathetic fibres, travelling along the tentorium cerebelli, 
enter the pineal gland via the conarian nerve (Ebadi et al., 1986). This is diagrammatically 
represented in Figure 1.2. 
EYE 
MELATONIN 
5 
R 
I E RETINO-
I T '--_.-l HYPOTHALAMIC 1-__ 
I I TRACT IN 
rA 
SUPRACHIASMATIC 
NUCLEUS 
PINEAL GLAND 
.CYClIC AMP ADENYLATE BETA ADRENERGIC 
RECEPTOR CYCLASE 
RECEPTOR 
RETRO-
CHIASMATIC 
HYPOTHALAMUS 
FIGURE 1.2 Schematic representation o/pineal neural control (Adapted from Klein, 1979). 
NA = nor-adrenaline; cyclic AMP = adenosine 3' ,5'-cyclic monophosphate; 
Tp = tryptophan; HTp = 5-hydroxytryptophan; HT = Serotonin; HIAA = 
5-hydroxyindoleacetic acid; HTOH = 5-hydroxytryptophol; NAS = N-
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1.3 The Pineal Cells 
There appears to be some confusion amongst researchers as to the nomenclature of pineal cell 
categories. Very often cells with different morphological characteristics are given the same 
name and similar cells given different names. 
1.3.1 Cell Categories 
1.3.1.1 Category One 
These cells are characterised by the presence of granular vesicles. They have been shown 
to originate from the photoreceptor cells present in the pineal organ which collectively belong 
to the sensory cell line and are termed pinealocytes or pinealocytes sensu stricto (Wolfe, 
1965; Collin, 1971; Pevet and Collin, 1976; Pevet et al., 1977). 
1.3.1.2 Category Two 
The cells in this category are characterised both by their location close to the perivascular 
space and the absence of granular vesicles. They are usually termed interstitial or glial cells 
(Wolfe, 1965). There is still speculation as to whether the cells in this category originate 
from the same sensory cell line described by Collin (1971) (§ 1.3.1.1), although the opinion 
to date is that they do not. 
The rat, cow, mule and dog have been shown to have only a single population of pinealocytes 
sensu stricto while the guinea-pig, chinchilla, mouse and rabbit have been shown to have cell 
groups other than the pinealocytes sensu stricto. These cells do not originate from the 
sensory cell line as described by Collin (1971), which suggests that different populations of 
pinealocytes could exist (Reiter, 1981). 
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1.3.2 Pinealocyte Ultrastructure 
1.3.2.1 Nucleus 
The nuclei of pinealocytes are surrounded by an envelope consisting of perinuclear cisternae 
bridged by nuclear pores. Chondratin strands, arranged in granular and helical masses, are 
found within the envelope. The nucleoli are composed of amorphous areas surrounded by 
a dense nucleolonema. Ribonucleoprotein granules are also present. 
1.3.2.2 Cell Organelles 
Concentric Lamellae: Concentric lamellae are membrane-whorls found in the cytoplasm of 
the pinealocyte. The functions of these lamellae are unclear. Greater numbers of lamellae 
are found in actively secreting cells, which suggests that their formation is in some way 
related to the secretory process of the cell (pevet, 1976 and 1979). 
Mitochondria and Lipid Droplets: Mitochondria are found in all eukaryotic cells. They 
are energy-transducing systems which recover and convert the energy contained in food to 
the high energy phosphate bond of adenosine triphosphate (ATP). The pinealocytes contain 
large numbers of mitochondria, suggesting a high requirement for energy. 
Lipid droplets are also found in the cytoplasm of pinealocytes. Their role in the cell is 
believed to be of a metabolic nature. However, studies have shown that the number of lipid 
droplets fluctuates under changing conditions (Karasek, 1971), suggesting that lipid droplets 
could be either directly or indirectly involved in the process of synthesis and/or secretion in 
the pinealocyte (Pevet, 1979). 
Annulate Lamellae: Annulate lamellae is a collective term given to a number of structures 
within the pinealocyte. These structures are found in most mammalian pineals but their 
function is at present unknown. According to McNeil (1977), the lamellae could be derived 
from a modification of the granular endoplasmic reticulum. 
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Vesicle-Crowned Rodlets: A vesicle-crowned rodlet consists of an electron-dense rodlet 
surrounded by a single layer of small clear vesicles. These rodlets lie singly or in groups in 
the pinealocyte cytoplasm, very often close to the cell membrane (Reiter, 1981). 
A number of theories exist as to their function. Vollrath and Huss (1973) suggested that the 
vesicle-crowned rodlets (VCR) could be involved in intercellular communications between 
pinealocytes. VCR could possibly be excitatory structures alerting the physicochemical 
properties of neighbouring pinealocytes (Vollrath, 1973). 
The number, size and location of VCR appear to be dependent upon environmental 
illumination. A circadian rhythm in VCR numbers has been shown in the rat by Kurumado 
and Wataru (1977). 
Subsurface Cisterns: Subsurface cisterns are generally found close to the cell membrane in 
the perikarya of very active cells (Rosenbluth, 1962; Pevet, 1979). Their function is thought 
to be that of establishing a pathway for the exchange of metabolites or ions between 
neighbouring cells. 
1.3.2.3 Secretory Processes 
Many vesicles and organelles found within the cytoplasm of pinealocytes are responsible for 
the secretion of two major compounds giving the pineal gland its endocrine capabilities. 
These secretions usually take the form of indoleamines and peptidergic compounds (Reiter 
et al., 1975). 
There are two active secretory processes in the pinealocyte. The first involves the formation 
of granular vesicles by the Golgi apparatus. The second, termed the ependymal-like secretory 
process, involves the formation of cisternae by the granular endoplasmic reticulum (Pevet, 
1979). 
Granular Vesicles: Granular vesicles have been observed in the pinealocytes of practically 
all mammalian species (Pevet, 1979). They originate from the Golgi saccules and are found 
in perikarya as well as in the processes of the pinealocytes. It is generally accepted that the 
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granular vesicles migrate to the ends of the processes to release their contents into the 
perivascular space (Reiter, 1981). 
It is thought that granular vesicles release their contents in a packaged form, the main product 
of secretion being an antigonadotrophic compound (Kappers, 1976; Benson and Krasovich, 
1977; Upson and Benson, 1977; Reiter, 1978). 
Ependymal-like Secretory Process: This secretory process is linked to the activity of the 
granular endoplasmic reticulum. This activity leads to either an accumulation of 
proteinaceous material in its cisterns or to the formation, by the cisterns, of vacuoles 
containing flocculent material (Karasek and Marek, 1978). It is proposed that the product 
of secretion is an antigonadotrophic compound which plays an important part in pineal 
physiology (pevet, 1976). 
1.4 Pineal Biochemistry 
1.4.1 Circadian Rhythms 
A circadian rhythm may be defined as a periodic event recurring approximately every 24 
hours. Three processes in the pineal have been linked to a circadian rhythm, namely: 
locomotor activity (Gaston and Menaker, 1968), photoperiodic time measurement (Elliot et 
al., 1972; Elliot, 1976) and daily colour changes (Hafeez and Quay, 1970; Bagnara and 
Hadley, 1978). 
Serotonin, a pineal gland indole, exhibits considerable daily fluctuations (Quay, 1963; Fiske, 
1964). Serotonin levels were found to be high during the day and low at night, with 
corresponding high levels of melatonin at night and low levels during the day. These daily 
fluctuations of pineal indoles have been linked to the rhythms present in the enzymes 
hydroxyindole-O-methyltransferase (HIOMT) and serotonin-N-acetyltransferase (NAT) 
(Axelrod et aI., 1965; Klein et ai., 1970; Klein, 1972; Binkley et ai., 1973). The presence 
of a HIOMT rhythm has, however, been disputed by a number of investigators. 
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NAT and melatonin rhythms in rats have been shown to persist for up to two weeks in 
constant darkness and dampen in constant light (Ralph et al., 1971; Deguchi, 1975). Light 
intensity also affects the degree of NAT activity (Minneman et al., 1976) and unexpected 
dawn (light) transitions imposed on rats during the dark period (night) result in a rapid 
decrease in NAT activity and melatonin (Klein and Weller, 1972). 
1.4.2 Inorganic Constituents 
The principal calcareous component of human pineal corpora anenacea is hydroxyapatite 
(CalO(P04)6(OH):z). The presence of carbonite apatite (Ca lO(P04,C03,OH)6(OH)6) has been 
shown as well (Angervall et al., 1958; Earle, 1964). Histochemical studies have shown the 
presence of iron in the superficial lamellae of the corpora anenacea. Magnesium and 
strontium have also been reported in small concentrations (Bayerova and Bayer, 1960; 
Saliichuk, 1964; Krstic, 1976). 
The pineal gland has high concentrations of copper, manganese and zinc compared with other 
tissues and organs. It is likely that these constituents are chiefly associated with specific 
proteins and enzymes (Wong and Fritze, 1969). 
Recorded pineal calcium concentrations vary between different researchers, but it is 
understood that calcium contributes to molecular control mechanisms within the pineal 
(Pizarro et al., 1989). These control mechanisms pertain to: sensitivity of pineal ~-receptors 
(Wilkinson et al., 1976; Wilkinson, 1978), closure of pineal canaliculi (Quay, 1974a) and 
the induction of enzymes participating in pineal catechol- and indoleamine synthesis. These 
enzymes include adenylate cyclase, cyclic-AMP phosphodiesterase, tyrosine hydroxylase and 
N-acetyltransferase (Cantor and Weiss, 1978; Zatz and Romero, 1978). 
1.4.3 Amino Acids 
The amino acids present in the pineal gland contribute to both regulatory mechanisms as well 
as to pathways of general metabolic importance. 
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Aromatic amino acids are of particular importance in the pineal gland since they include the 
precursors to chemical mediators of the catechol-, imidazol-, and indoleamine series. 
1.4.4 Nucleotides 
11 Adenine nucleotides and their derivatives have diverse critical roles in both energy and 
biosynthetic control mechanisms within the pineal gland 11 (Quay, 1974b). 
S-adenosylmethionine (SAM) is synthesized in pineal tissue from adenosine triphosphate 
(ATP) and methionine. SAM has a wide array of biological transmethylation reactions in the 
pineal gland (Guchait and Grau, 1978), including the methylation of biogenic amines 
(Deguchi and Barchas, 1971). 
Of all the pineal nucleotides, cyclic adenosine 3' ,5' -monophosphate (cAMP) receives the 
greatest attention. It is often termed the second messenger responding to particular hormonal 
or neurotransmitter molecules. Daily fluctuations in cAMP occur in the pineal, with peaks 
occurring ten hours after the onset of daily light and troughs ten hours after the onset of 
darkness (Ebadi et al., 1971). 
The synthesis of cAMP is dependent upon the availability of A TP and the activity of 
adenylate cyclase, a membrane bound enzyme. Nor-adrenaline stimulation of .B-receptors 
results in increased levels of cAMP (Strada et al., 1972). 
1.4.5 Lipids and Carbohydrates 
Lipids form between 3 % and 10 % of the wet weight of the pineal gland. More than half of 
this is phospholipid, with most of the remainder consisting of free cholesterol and glycerides. 
Of the pineal phospholipids, phosphatidyl choline and phosphatidyl ethanolamine form the 
majority (Hauser and Nijjar, 1976 and 1977). 
Studies on pineal carbohydrates have concentrated on the ultrastructural localisation and 
changes in glycogen deposits. Radio-label studies have shown the pineal gland to behave 
more like an endocrine gland than brain tissue in relation to carbon dioxide production. 
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Where the brain uses the Embden-Meyerhof pathway, the pineal gland uses the pentose 
phosphate pathway (Krass and LaBella, 1966 and 1967). 
1.4.6 Pineal Proteins 
The pineal's content of soluble protein may be placed into two classes viz. endogenous and 
exogenous. The pineal has been found to have a high capacity for exogenous peptide uptake. 
Examples of peptides are: thyroid releasing hormone, luteinizing hormone-releasing 
hormone, a-melanocyte-stimulating hormone (a-MSH), MSH-releasing inhibiting factor, 
somatostatin and methionine-enkephalin (Redding et al., 1973; Dupont et al., 1975; Nair 
and Colwell, 1975; Kastin et al., 1976). Other peptides identified in pineal tissue include 
lysine vasotocin, nerve growth factor, delta-sleep inducing peptide, S-loo protein and glial 
fibrillary acidic protein (Kastin et al., 1978; Moller et al., 1978; Perez-Polo et al., 1978). 
1.5 Pineal Indole Compounds 
1.5.1 Tryptophan 
Tryptophan concentrations in the pineal gland are a function of the tryptophan in circulation 
which is controlled by the liver's cytosolic enzyme, tryptophan pyrrolase (Badaway, 1979). 
The administration of 5-aminolevulinic acid (5-ALA) was shown to increase tryptophan 
pyrrolase activity in rats with a resultant decrease in tryptophan levels in forebrain regions 
(Daya et al., 1989). Pineal gland studies, however, showed that tryptophan levels remained 
unaffected by 5-ALA administrations (Daya et al., 1989). Deguchi and Barchas (1972) 
demonstrated that injections of tryptophan could result in elevated pineal tryptophan levels. 
1.5.2 SerotoEdn 
Serotonin in the pineal gland is synthesised predominately in the pinealocyte (Fuller and 
Perry, 1977). Three factors which regulate the concentration of serotonin in the pineal gland 
are: 
the synthesis-loading of the pinea10cyte with tryptophan (which increases serotonin) 
the rate at which serotonin is converted to oxidised products, and 
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the rate at which serotonin is converted to N-acetylserotonin by the enzyme serotonin 
N -acety ltransferase (NAT). 
Increasing or decreasing the activity of NAT has a direct reciprocal effect on serotonin 
concentrations (Klein et al., 1973) (Figure 1.3). 
1.5.3 N-Acetylserotonin 
The levels of N-acetylserotonin (NAS) are directly controlled by NAT. When NAT activity 
is high, as is the case at night, NAS levels are elevated. The opposite occurs during the day 
(Brownstein et al., 1973; Klein and Weller, 1973). 
1.5.4 Melatonin 
In 1917 McCord and Allen reported that amphibians fed with bovine pineal extracts exhibited 
skin lightening. It was not until 1957 that the active compound was isolated by Lerner and 
co-workers, and was termed 5-methoxy-N-acetyltryptamine (Lerner et al., 1958). The name 
was later changed to melatonin because of its blanching effect on melanophores (Lerner et 
al., 1959; Lerner and Case, 1960). 
Melatonin was originally thought to be synthesised only in the pineal gland. The basis for 
this speculation was the distribution of the enzyme HIOMT (Axelrod et al., 1965). However, 
research has shown that melatonin is synthesised in other tissues, but to a lesser extent. 
These tissues are the retina, intestine and Harderian gland (Cardinali and Rosner, 1972; 
Cardinali and Wurtman, 1972; Bubenik et al., 1977; Pang et al., 1980). 
Melatonin is very lipophilic and is found to permeate many parts of the body, such as the 
brain, peripheral nerves and sympathetic nerve chain (Wurtman et al., 1964). 
Once synthesised, melatonin is released into the circulation where most of it is found 
associated with serum albumin (Cardinali et al., 1972; Arendt, 1978). In the liver, 
melatonin is metabolised to 6-hydroxymelatonin. 
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FIGURE 1.3 Daily rhythms in serotonin metabolism in the rat pineal gland (Reiter, 1981). 
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Melatonin is found in most mammals, indeed most vertebrates. It's synthesis follows a 24 
hour cycle, with a peak being reached at night. Seasonal physiological adjustments, such as 
those involved in breeding patterns and hibernation seem to be the major function of the 
hormonal response of the pineal gland (Arendt, 1986; Reiter, 1988a). 
Melatonin receptor populations have been found in the hypothalamus (Reppert et ai., 1988), 
pars tuberalis of the pituitary gland (Morgan and Williams, 1989) and the hipocampus 
(Zisapel, 1988). This indicates that melatonin could playa role in the regulation of these 
tissues. These discoveries were made possible by the use of 2-iodomelatonin, a potent 
melatonin analogue (Vakkuri et ai., 1984). 
1.5.4.1 Melatonin Hypotheses 
Reiter (1987) suggested three main hypotheses regarding hormonal rhythms, namely: 
the duration hypothesis 
the coincidence hypothesis, and 
the amplitude hypothesis. 
The duration hypothesis, as the name implies, takes into account the duration of nocturnal 
melatonin levels. According to this hypothesis, as seasons change, the animal is exposed to 
different durations of melatonin i. e. longer exposure during winter (long nights) than during 
summer (short nights) (Reiter, 1991). 
This hypothesis has been extended to "take into account the direction of change of elevated 
nocturnal melatonin i. e. whether the period of elevated levels is becoming longer as the 
season changes to winter, or shorter, as summer approaches" (Brown, 1992). 
The coincidence hypothesis implies that, although the nocturnal highs of melatonin are 
important they are immaterial unless the organ is receptive to those levels of melatonin at that 
particular point in time (Carter and Goldman, 1983; Stetson and Watson-Whitmyre, 1986). 
The amplitude hypothesis examines the magnitude of the nocturnal rise of melatonin (Berga 
et ai., 1988). The importance of this hypothesis lies in its ability to be used as a diagnostic 
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tool i. e. "humans often show altered melatonin levels in the presence of certain disease states" 
(Brown, 1992). 
1.5.4.2 Reported Influences of Melatonin 
As reported by Brown (1992) melatonin has been shown to be implicated in: 
i. Reproduction: melatonin causes a marked reduction in sperm motility and at high 
concentrations, which are still within normal physiological values, completely 
abolishes movement (Oosthuizen et al., 1986). 
11. Hormonally dependent tumours e.g. women with breast cancer often have enlarged 
pineals (Blask, 1984). Pinealectomised rats show little resistance to cancer growth 
while melatonin administration reduces cancer growth (Reiter, 1989). 
111. Immunocompetence: melatonin administrations have been shown to enhance the 
immune response (Pierpaoli and Maestroni, 1987). 
iv. Stress and its effects e.g. stress related ulcers. Prior melatonin administrations caused 
a significant reduction in gastric ulcerations in stressed male rats (Khan et al., 1990). 
v. Sudden infant death syndrome (Sparks and Hunsaker, 1988). 
vi. Changes in environmental light e.g. "jet-lag". Melatonin administration appears to 
shorten the re-entrainment of the circadian rhythm (Turek, 1987). 
V11. Ageing. Relative melatonin deficiencies with persistent serotonin have been reported 
to promote ageing (Rozencwaig et al., 1987). 
V111. Seasonal affective disorder syndrome (SADS). In the Northern Hemisphere patients 
may experience a depressive state of mind between December and February, which 
when treated with light (which impliedly reduces levels of plasma melatonin) causes 
an improvement (Ebadi and Govitrapong, 1986). 
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1.6 Pineal Indole Metabolism 
The pathways involved in the metabolism of pineal indoles are schematically represented in 
Figure 1.4. 
Serotonin is synthesised from tryptophan in a process involving two enzymes, namely 
tryptophan hydroxylase and aromatic amino acid decarboxylase (Lovenberg et ai., 1967). 
Tryptophan is first converted to 5-hydroxytryptophan by tryptophan hydroxylase in the 
mitochondria (Rori et ai., 1976). This appears to be the rate-limiting step in the synthesis 
of serotonin from tryptophan. Tryptophan hydroxylase, like other mammalian aromatic 
hydroxylases, requires a pteridine co-factor to function. High concentrations of pteridine co-
factors are found in the pineal gland (Levine et ai., 1979). 
5-Hydroxytryptophan is converted to serotonin by the enzyme aromatic amino acid 
decarboxylase. This enzyme is non-specific and is found in most tissues (Christenson et ai., 
1972). Within the pineal, the enzyme is located in the cytosol and requires a pyridoxal 
phosphate to function (Snyder et ai., 1965a). 
The next step involves the acetylation of serotonin to N-acetylserotonin by the enzyme 
serotonin N-acetyltransferase (NAT) with the co-factor acetyl coenzyme A being the acetyl 
donor (Weissbach et ai., 1960). N-acetylserotonin is converted to melatonin by 0-
methylation in the 5-position by the enzyme hydroxyindole-O-methyltransferase (HIOMT). 
Serotonin may be metabolised by way of a second pathway, involving deamination and 
oxidation reactions. Serotonin is oxidised to 5-hydroxyindole acetaldehyde by the enzyme 
monoamine oxidase (Axelrod et ai., 1969). The acetaldehyde is then converted to 5-
hydroxyindoleacetic acid by aldehyde dehydrogenase (Wurtman and Larin, 1968). Part of 
the 5-hydroxyindole acetaldehyde is also converted to 5-hydroxytryptopho1 by alcohol 
dehydrogenase (McIsaac and Page, 1959) and is then methoxylated by HIOMT to form 5-
methoxytryptophol (Wurtman and Axelrod, 1967). 
In the final reaction, serotonin may also be methoxylated by HIOMT to form 5-
methoxytryptamine. 
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1.7 The Pineal Beta-Adrenergic Receptor 
The earliest characterisation of the pineal (j-receptor was made using indirect methods. These 
methods involved the measuring of adenylate cyclase activity, an enzyme linked to the (j-
adrenergic receptor, in the presence of (j-receptor agonists and antagonists (Weiss and Costa, 
1968). Further studies confIrmed the presence of .a-receptors and that nor-adrenaline acted 
via these receptors (Deguchi, 1973; Klein and Weller, 1973; Klein and Yuwiler, 1973). 
With the advent of direct receptor binding techniques it became possible to measure the 
number and affmity of the .a-receptors (Kebabian et al., 1975; Zatz et al., 1976). The use 
of [3H]-dihydroalprenolol (DHA) , a specific (j-receptor radio-ligand, allowed the measurement 
of receptor numbers. Further DHA studies showed that .a-receptor numbers changed as a 
function of adrenergic stimulation. Animals maintained under constant light, or which were 
treated with adrenergic agonists during times when this stimulation was not naturally present, 
showed either a 50 % fall or rise in receptor numbers. This phenomenon of a rise in receptor 
numbers during the day and a fall in numbers at night is referred to as sub sensitivity and 
supersensitivity respectively. As a result of these changes, a diurnal rhythm in receptor 
numbers exists (Kebabian et al., 1975). 
Direct binding studies clearly indicate that the changes in receptor numbers have no effect on 
the receptor's affInity for agonists (Romero et al., 1975; Zatz et al., 1976). Receptor 
numbers have been shown to be affected by age i. e. receptor numbers decrease with an 
increase in age. The large day-night differences found in younger rats decrease in ageing 
animals (Greenberg and Weiss, 1978; Weiss et al., 1979). 
The effect of a .a-receptor agonist is conveyed into the cell via the synthesis of cAMP from 
A TP (Weiss and Costa, 1968). The enzyme adenylate cyclase catalyses the above reaction 
and has been shown to be a separate protein to the .a-receptor. Adenylate cyclase is linked 
to the .a-receptor by a regulatory G protein which functions as a coupling transducer. G 
proteins are divided into two groups, namely Gs (stimulatory G protein) and Gj (inhibitory 
G protein) according to their Cl subunits (Cls and ClU (Taylor and Merritt, 1986). In the pineal, 
the stimulation of .a-adrenergic receptors results in the activation of adenylate cyclase via a 
stimulatory guanine nucleotide-binding regulatory protein (GJ (Spiegel, 1989). This 
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receptor/enzyme complex is located entirely in the plasma membrane, with the G protein 
binding to it at the cytosolic face of the membrane (Pfeuffer, 1977; Cassel and Pfeuffer, 
1978; Ross et aI., 1978; Kaslow et aZ., 1979). 
The concentration of cAMP in the pinealocyte is controlled primarily by its rate of synthesis 
and its rate of destruction. Large daily fluctuations in the cAMP concentration have been 
linked to stimulation of .a-receptors. Shortly after .a-adrenergic receptor stimulation the 
amount of cAMP in the pineal gland increases about l00-fold (Strada et al., 1972; Deguchi, 
1973; Klein et aZ., 1978). A peak is reached five to 15 minutes after stimulation, but it is 
not sustained. The gradual decrease in cAMP concentration is related not to the continued 
presence or absence of .a-receptor agonists, but rather to a decrease of adenylate cyclase 
activity. 
Cyclic AMP is inactivated to 5' -adenosine monophosphate (5 ' -AMP) by the enzyme pineal 
cAMP-phosphodiesterase. This enzyme has been demonstrated to have both a low- and a 
high-Km form (Oleshansky and Neff, 1975). Minneman and Iverson (1976) showed that the 
amount of phosphodiesterase activity was a function of adrenergic stimulation. Isoproterenol 
stimulation resulted in a 50% increase in the low-Km enzyme, with the activity returning to 
basal levels some five hours after stimulation was terminated (Oleshansky and Neff, 1975). 
Minneman and Iverson (1976) further showed a diurnal change in phosphodiesterase activity, 
with higher activity at night. 
The current concept of cAMP's mode of action is that it acts through the activation of an 
enzyme, protein kinase A, which phosphorylates other proteins and enzymes. In this way, 
enzymes involved in pineal indole metabolism are activated, resulting in the synthesis of 
melatonin. 
1.8 The Pineal Alpha-Adrenergic Receptor 
The presence of ex-receptors in the pineal gland was originally demonstrated by Vacas et aI., 
(1980) and later confirmed by Sugden and Klein (1984). Smith et aZ. (1979), demonstrated 
that ex-receptors were located post-synaptically. Sugden and Klein (1985) further showed 
that, unlike .a-adrenergic receptors, the ex-receptors showed no circadian rhythm. It was 
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demonstrated that these receptors were under neural control and that chronic treatment of the 
receptors with agonists failed to change the receptor numbers. The change in .a-receptor 
numbers was suggested by Stadel et al. (1983) to be a process involving internalisation and 
recycling rather than a slower process of synthesis and degradation. On the other hand it is 
believed that a-receptor numbers vary as a result of their synthesis and degradation 
(Sladeczek and Bockaert, 1983; Sugden and Klein, 1985). 
a2-Receptors are also detectable in rat pineal glands and are situated pre-synaptically. Nor-
adrenaline release has been shown to be regulated via a feedback mechanism mediated by 
these receptors (pelayo et al., 1977). 
1.9 Enzymes Involved in Pineal Indole Metabolism 
1.9.1 Tryptophan Hydroxylase 
Tryptophan hydroxylase catalyses the conversion of tryptophan to 5-hydroxytryptophan in the 
mitochondria of pinealocytes (Romijn et al., 1977). The enzyme requires a pteridine co-
factor, probably tetrahydrobioterin, to function (Levine et al., 1979). The half-life of the 
enzyme has been found to be 75 minutes which suggests that the enzyme is being continually 
synthesised in the cell in order to maintain the levels at which it occurs (Sitaram and Lees, 
1978). 
The enzyme was successfully purified to a 1 ooo-fold purification by Nukiwa et al. (1974) 
and was shown to have a molecular weight of 30 000. The Km for tryptophan was shown 
to be 16 ,uM. 
Pineal tryptophan hydroxylase differs from brain tryptophan hydroxylase. The most 
significant difference is related to the circadian rhythm of the enzyme. At night, pineal 
tryptophan hydroxylase almost doubles, whereas there is relatively little daily change in the 
activity of this enzyme in the various regions of the brain, including the hypothalamus 
(Shibuya et al., 1978). 
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It has been suggested that pineal tryptophan hydroxylase is regulated by its diurnal rhythm 
which appears to be endogenously generated and persists in darkness. The enzyme's rhythm 
is suppressed in constant light. Propranolol blocks the nighttime increase in activity of this 
enzyme, suggesting that nor-adrenaline may be the neurotransmitter involved in its regulation 
(Shibuya et al., 1978). 
Substrate concentration is an important regulatory mechanism for this enzyme. An increase 
in tryptophan was shown to result in an increase in the rate of serotonin formation in the 
pineal gland (Deguchi and Barchas, 1972; Bensinger et al., 1974). 
1.9.2 Aromatic-I-Amino Acid Decarboxylase 
Aromatic-I-amino acid decarboxylase is a non-specific enzyme found in all body tissues, but 
is present in higher concentrations in the pineal gland (Lovenberg et al., 1962; Christenson 
et al., 1972) where it is located in the cytoplasm (Snyder and Axelrod, 1964). Pyridoxal 
phosphate is required by the enzyme as a co-factor in its decarboxylation of 5-
hydroxy tryptophan to serotonin (Lovenberg et a!., 1962). 
The activity of the enzyme has been shown by Snyder et a!. (1965b) to be influenced by 
environmenta1lighting acting through the sympathetic nerves. Animals exposed to constant 
light showed an increase in enzyme activity whereas those kept in constant darkness did not. 
This suggests that adrenergic stimulation results in a depression of enzyme activity (Snyder 
et al., 1964). 
1.9.3 Monoamine Oxidase 
Indoleamines in the pineal gland are oxidatively deaminated, as in other tissues, by a process 
initiated by the action of monoamine oxidase. This enzyme converts monoamines to their 
corresponding aldehydes. The aldehydes are immediately converted to either acid or alcohol 
by aldehyde dehydrogenase or alcohol dehydrogenase respectively (Feldstein and Williamson, 
1968; Keglevic et al., 1968). 
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Monoamine oxidase is situated within the mitochondria of pinealocytes and in the nerve 
endings of nerves innervating the pineal gland (Goridis and Neff, 1971; Yang et al., 1972). 
In the nerve endings its function is to inactivate neurotransmitter amines such as nor-
adrenaline and adrenaline. 
The enzyme differs between the pinealocyte and nerve endings. It has thus been classified 
into two types namely, type A and type B (Johnson, 1968). Type A is primarily found in the 
sympathetic nerve terminals and is inhibited by the inhibitor clorgyline. The enzyme is 
relatively heat stable and is easily inactivated by trypsin. Type A accounts for about 15% 
of the pineal monoamine oxidase and acts on tryptamine, tyramine and serotonin (Yang et al. , 
1972). 
Type B is found predominantly in the pinealocyte and is heat labile but is not as readily 
inactivated by trypsin or inhibited by c10rgyline (Yang et aI., 1972). 
1.9.4 Alcohol Dehydrogenase 
Alcohol dehydrogenase converts the 5-hydroxyindoleacetaldehyde formed by the action of 
monoamine oxidase to 5-hydroxytryptophol. The enzyme requires a reduced pyridine co-
factor for the above reaction (Feldstein and Williamson, 1968; Keglevic et al., 1968; 
Tabakoff, 1977). 
1.9.5 Aldehyde Dehydrogenase 
Aldehyde dehydrogenase converts aldehydes into acids, such as 5-hydroxyindoleacetaldehyde 
into 5-hydroxyindoleacetic acid. In catalysing this reaction, the enzyme requires an oxidised 
pyridine co-factor (Feldstein and Williamson, 1968; Keglevic et al., 1968; Tabakoff, 1977). 
1.9.6 Hydroxyindole-O-Methyltransferase 
Hydroxyindole-O-methyltransferase (HIOMT) belongs to a group of enzymes that transfer 
methyl groups from S-adenosylmethionine to acceptor molecules. In the pineal gland the 
acceptor molecules are 5-hydroxyindoles (Axelrod and Weissbach, 1961). 
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HIOMT is found in high concentrations in the pineal gland and in lower concentrations in the 
retina, Harderian gland and intestine of mammals (McIsaac et at., 1965; Jackson and 
Lovenberg, 1971). 
In the pineal gland HIOMT catalyses the conversion of N-acetylserotonin to melatonin and 
to a lesser extent converts 5-hydroxyindoleacetic acid to methoxyindoleacetic acid; 
hydroxytryptamine to methoxytryptamine; and hydroxytryptophol to methoxytryptophol 
(McIsaac et at., 1965; Jackson and Lovenberg, 1971). 
HIOMT is located entirely in the cytosol of the pinealocyte. The enzyme is abundant within 
the cell and accounts for approximately 2 % - 4 % of its soluble protein. The enzyme has a 
molecular weight of approximately 78 000 and appears to have two sub-units, each with a 
molecular weight of 39 000 (Karahasanoglu and Ozand, 1972; Kuwano and Takahashi, 
1978). 
HIOMT follows a daily rhythm (Klein, 1972) and is regulated in vivo by two mechanisms, 
namely light acting to modulate neural stimulation and by circulating steroids altering the 
activity of the enzyme (Preslock, 1977; Klein and Moore, 1979). 
A change in environmental lighting slowly changes pineal mOMT activity (Axelrod and 
Wurtman, 1978). Exposure of animals to constant darkness increases the activity of the 
enzyme through an increase in HIOMT molecules (Yang and Neff, 1975). Conversely, 
exposure to constant light reduces enzyme activity (Wurtman et at., 1963; Axelrod et at., 
1965). This has however been disputed by many authors. The neural pathway regulating this 
enzyme involves the retinohypothalamic projection which innervates the suprachiasmatic 
nucleus, the retrochiasmatic hypothalamus and peripherally, the superior cervical ganglia 
(Klein and Moore, 1979). 
Circulating gonadal steroids have been shown to participate in HIOMT regulation (Preslock, 
1977). Testosterone increases HIOMT activity at low concentrations and decreases the 
enzyme activity at high concentrations. Estradiol at nanomolar concentrations increases 
HIOMT activity by between 50 % and 80 % (Mizobe and Kurokawa, 1976). 
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1.9.7 Serotonin N-Acetyltransferase 
Serotonin N-acetyltransferase (NAT) is the enzyme responsible for the conversion of 
serotonin to N-acetylserotonin (Weissbach et al., 1960). NAT has a diurnal rhythm, with its 
activity being 30 - 70 fold higher at night (in the dark) than during the day (Deguchi and 
Axelrod, 1972a; Ellison et al., 1972; Romero et al., 1978). These large changes in enzyme 
activity are believed to be controlled via a photic-neural pathway (Klein, 1979). 
Voisin et al. (1984) established the presence of two distinct NAT enzymes in the rat pineal 
gland. The enzymes were termed arylamine N-acetyltransferase and arylalkylamine N-
acetyltransferase as a result of the arylamines and aryla1kylamines they respectively acetylate. 
Isoproterenol treatment of arylalkylamine N-acetyltransferase increased its activity 1OO-fold 
without increasing arylamine N-acetyltransferase activity. The two enzymes were found to 
become inactivated at different rates at 4°C, while on size exclusion chromatography, the 
enzymes were resolved in two different bands. Voisin et al. (1984) observed that 
arylalkylamine N-acetyltransferase was independently regulated and was primarily responsible 
for the physiological conversion of serotonin to melatonin via the intermediate N-
acetylserotonin. 
1.10 Serotonin N-Acetyltransferase : Regulatory Mechanisms 
1.10.1 Circadian Control of NAT 
The rat pineal NAT rhythm is truly circadian as it persists even in a non-periodic 
environment i.e. constant darkness (Klein and Weller, 1970). The rhythm is abolished by 
denervation of the gland through bilateral superior cervical ganglionectomy (Klein et al., 
1971). The rhythm is thus controlled by a circadian pacemaker located outside the gland, 
most probably in the suprachiasmatic nuclei (SCN) of the hypothalamus (Klein and Moore, 
1979). Signals sent from the SCN stimulate a phase of NAT activity at night (Binkley et al. , 
1974; lllnerova, 1974). 
In constant darkness the endogenous pacemaker controlling the NAT rhythm may free-run 
with its own period close to 24 hours. The external light-dark cycle generated by the earth's 
26 
rotation may serve as an entraining agent and may force circadian systems to run with a 
period of 24 hours. Light in each light-dark cycle must change the period of the pacemaker 
by an amount proportional to either a phase-advance in short daylight days (winter) or a 
phase-delay in long daylight days (summer). Thus, the entrainment of the circadian system 
to the 24 hour day is achieved by a phase-shifting of the pacemaker by light (Illnerova et al., 
1989; llinerova and Humlova, 1990). 
Neural regulation of the NAT rhythm occurs via signals, originating in the SCN of the 
hypothalamus, being transmitted to the pineal by a neural circuit which includes superior 
cervical ganglia of the sympathetic nervous system (Kappers, 1960). Sympathetic nerve 
endings in the pineal release the neurotransmitter nor-adrenaline, which, through I'-adrenergic 
and partly a-adrenergic receptors and the cAMP system, induces and activates N-
acetyltransferase (Klein et al., 1983). Nor-adrenaline release is found to be high at night and 
low during the day (Brownstein and Axelrod, 1974) (Figure 1.5). 
1.10.1.1 The Suppressive Effect of Light on the NAT Rhythm 
The rat pineal NAT rhythm is abolished by the exposure of animals to constant light (Klein 
and Weller, 1970). The pineal melatonin pathway is affected by an abrupt light exposure at 
night. Serotonin concentrations in the pineal were shown to increase from a nighttime low 
to a daytime high, within a 14 minute period, after exposure of animals to a one minute light 
burst (Illnerova, 1971). Similarly, melatonin concentrations decrease with a half-time of 
approximately five minutes after light exposure (Illnerova et al., 1978). NAT was also 
shown to decline rapidly after sudden light exposure at night (Deguchi and Axelrod, 1972a; 
Klein and Weller, 1972). 
The sensitivity of NAT to light is characterised by the colour and intensity of the light. 
White, blue and green light have been shown to markedly inhibit NAT activity, while red 
light appears to exert no effect on the enzyme's activity (Cardinali et al., 1972). Light 
intensities ranging between full moon (0.03 - 0.05 p.W/cm2) and full sunlight (50 000 p.W 
Icm2) have been shown to reduce NAT activity (Biberman et al., 1966). However, maximal 
inhibition of NAT was found with light at an intensity less than 15 p.W/cm2 (Minneman et 
ai., 1976). 
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pinealocyte (Reiter, 1988b). 
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The mechanism for NAT's loss of activity is not fully understood. However, a study by 
Illnerova and Vanecek (1979) on rats exposed to light at night showed a rapid decline in NAT 
activity over the first 12 minutes to 10% of its former value half-time of 3.8 minutes and then 
slowly with a half-time of 70 minutes. 
The same biphasic decline was found in rats injected with the {3-adrenergic blocker, 
trimepranol, at night in darkness (Illnerova and Vanecek, 1979). It was thus concluded that 
light exposure at night caused a reduced or complete "shut-off" of nor-adrenaline release from 
nerve endings in the pineal gland. Deguchi and Axelrod (1972b) reported a similar result to 
Illnerova and Vanecek (1979), for the decrease in NAT activity at night after the blockage 
of protein synthesis. It was thus postulated that light interrupts the synthesis of the enzyme. 
In contrast to rat pineal NAT, chick pineal NAT rhythm is not affected by bilateral 
denervation of the superior cervical ganglion or by injections of catecholamines (Binkley et 
al., 1975; Ralph et al., 1975). 
Organ culture experiments involving chick pineal glands demonstrated that chick pineal NAT 
activity exhibited a circadian change comparable with that of the rhythm in vivo (Binkley and 
Mosher, 1989). When cultured in darkness, pineal NAT activity autonomously increased at 
midnight and decreased during the day. The pattern was found to be similar in the chick 
pineal regardless of the time of sacrifice, which indicated a possible timekeeping system. 
Further studies showed that the rhythmical rise and fall of NAT activity, in vivo, only 
occurred for one cycle in constant darkness. This indicated that either chick pineals could 
keep the schedule for only one cycle in the absence of a light-dark cycle, or that the 
timekeeping system in the chick pineals could desynchronize between pineal glands or even 
between pinealocytes within a given gland (Deguchi, 1979). 
Recent work involving neonatal animals (Bronstein et al., 1990) showed that these animals 
reacted differently to a one minute light exposure at night. Animals six days old or older 
showed a suppression of pineal NAT activity after a one minute light exposure at night. This 
suppression was, however, not found in animals between three and five days of age even 
though they displayed clear light-dark differences in pineal NAT activity. Nighttime levels 
of NAT activity in seven day old animals, which had been bilaterally enucleated, were not 
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suppressed when the animals were exposed to a nocturnal light stimulus. This suggests that 
the effect is retinally mediated. 
1.10.2 The Effect of Inorganic Constituents on NAT Activity 
The stimulation of both transcription and translation is required for the nocturnal induction 
of pineal NAT activity (Romero et al., 1978). Inhibitors of both transcription and translation 
have been shown to block the nocturnal rise in enzyme activity (Romero et al., 1978). The 
most important inorganic constituents in the regulation of NAT activity are potassium, lithium 
and calcium. 
Work by Namboodiri et al. (1979) has shown that inorganic compounds such as sodium 
chloride, sodium phosphate, sodium fluoride, potassium fluoride, ammonium acetate and 
magnesium chloride prevent the loss of NAT activity over a 30 minute period. The decrease 
in inactivation caused by these salts appears to be due to an increase in ionic strength rather 
than an increase in molarity. The salts appear to have a non-specific effect on NAT and it 
is suspected that they affect the conformation of the enzyme (Namboodiri et al., 1979). 
1.10.2.1 Potassium 
High concentrations of potassium have been shown to inhibit the induction of NAT activity 
by nor-adrenaline (Parfitt et al., 1975). The effect of potassium appears to be secondary to 
the post-synaptic depolarization caused by elevated potassium or the prevention of the 
hyperpo1arisation caused by nor-adrenaline. 
1.10.2.2 Lithium 
Lithium, at therapeutic concentrations, has been shown to inhibit NAT activity by inhibiting 
intracellular increases in cAMP (Zatz, 1979). It is thought that lithium inhibits cyclic 
nucleotide synthesis by interfering with the role of divalent cations (Zatz, 1979). Thus, lower 
cellular levels of cAMP prevent NAT induction. 
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1.10.2.3 Calcium 
Of all the inorganic constituents of the pineal, calcium is by far the most important. This is 
evident in the role it plays in the decalcification of the pineal gland with age (Tapp and 
Huxley, 1972) and in the "calcium signal" as a component of nor-adrenergic regulation of the 
synthetic and secretory activity of the pineal gland (Sugden et al., 1987). 
Early work on the relationship between calcium ions and the pineal gland showed that 
extracellular calcium was necessary for complete induction of NAT activity in rats 
(Wilkinson, 1976; Zatz and Romero, 1978). Chelation of extracellular calcium led to a 
reduction in NAT activity by an indirect effect on protein synthesis (Zatz and Romero, 1978), 
and stimulation of ,8-adrenergic receptors required extracellular calcium for full expression 
of the activity of the acetylating enzyme (Wilkinson, 1976). 
Wilkinson (1976) further showed that long term exposure to elevated calcium concentrations 
led to a reduction in NAT activity, thus indicating a possible inhibitory role for calcium in 
addition to its stimulatory activity. The inhibitory effect of elevated intracellular calcium on 
rat pineal NAT has been suggested to be the result of activation of a NAT inhibitory 
substance in the pineal (Chan and Ebadi, 1981; Khoory and Schloot, 1986; Lerch! et al., 
1991). 
Research has shown that a-adrenergic receptors are involved in the regulation of the 
intracellular calcium ion concentration (Sugden et al., 1986 and 1987). In these studies the 
authors treated rat pinealocytes with a variety of adrenergic agonists and antagonists. The 
results strongly suggested the involvement of an a- rather than ,8-receptor. 
Calcium channel activity in the pinealocyte has also been shown to affect NAT activity (Zatz 
and Mullen, 1988; Zatz, 1989; Zawilska and Nowak, 1990). Blockade of calcium channels 
during the night resulted in the inhibition of normal nocturnal increase in NAT activity. This 
effect is prevented by the administration of calcium channel agonists (Zatz and Mullen, 1988; 
Zatz, 1989; Zawilska and Nowak, 1990). The enhancement of nocturnal NAT activity by 
calcium channel agonists suggests that the a-adrenergic augmentation of ,8-adrenergically-
stimulated NAT induction is the result of enhanced calcium channel-mediated calcium influx. 
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Recent work on rat and chick pineal gland homogenates has revealed that EGTA, a non-
specific ion chelator, prevents the loss of NAT activity during pre-incubation before substrate 
addition (Rodriguez-Cabello et al., 1990a and 1990b). 
Calmodulin's role in calcium's action: Calcium has increasingly been shown to play an 
important role in pineal function (Sugden et al., 1986 and 1987). Its role within the cell has 
been shown to be linked to the action of nor-adrenaline (Vanecek et al., 1985 and 1986). 
Research has shown that acadrenergic receptor stimulation together with ~-receptor 
stimulation potentiates cAMP production (Reiter, 1991). This potentiation is thought to act 
through a calcium/phospholipid-dependent protein kinase and cGMP (Sugden et al., 1986). 
Meyer et al. (1964) were the first to consider the possibility that calcium might require a 
binding protein to exert its effect within the cell. Calmodulin was found to be that binding 
protein. It consists of a single polypeptide chain containing 148 amino acids. The protein 
weighs 16 500 daltons and is heat stable. "Calmodulin has been implicated in conferring 
calcium sensitivity (i.e. Ca2+ -dependent activation) to approximately 30 different target 
proteins (for reviews see Cheung, 1980; Means and Dedman, 1980; Stoc1et, 1981; Manalan 
and Klee, 1984) and thus plays the role of the multi-functional intracellular calcium receptor" 
(Brown, 1992). 
Calmodulin contains four calcium binding sites (Dedman et al., 1978) with a dissociation 
constant of approximately 1O-6M (Klee, 1977; Wolff et al., 1977). Large conformational 
changes occur to calmodulin when it binds four calcium ions. These result in the exposure 
of a hydrophobic binding site, which in turn binds to target proteins and enzymes (LaPorte 
et al., 1980; Johnson and Wittenauer, 1983). 
Calmodulin's mode of action was first shown in the phosphodiesterase system (Haiech et al. , 
1981). Calmodulin is activated by the binding of four calcium ions to the calcium binding 
sites. The active form (more helical conformation) then binds to an inactive apo-enzyme of 
PDE, resulting in the formation of an active holo-enzyme (Haiech et al., 1981). 
The role played by calmodulin indirectly affecting NAT activity became apparent when it was 
found that both adenylate cyclase and cAMP-phosphodiesterase were activated by calmodulin. 
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Adenylate cyclase is activated at a much lower concentration of calcium than is cAMP-
phosphodiesterase. The result is that once the optimal calcium concentration for cAMP-
phosphodiesterase activation is reached, adenylate cyclase is already being inhibited. This 
is diagrammatically represented in Figure 1.6. 
1.10.3 Honnonal Influence on NAT Activity 
1.10.3.1 Estradiol 
NAT activity was found to be insensitive to estradiol treatment in rats (Illnerova, 1975; 
Preslock, 1975; Cardinali and Vacas, 1978). Estradiol administration also disturbed neither 
the light-dark cycles of NAT nor its induction by isoproterenol (Illnerova, 1975). Protein 
synthesis in the pineal gland is affected by estradiol (Cardinali et aZ., 1975) but this synthesis 
is unrelated to that of NAT. 
1.10.3.2 Progesterone 
"Progesterone, like estradiol, does not affect pineal NAT activity and therefore probably does 
not modulate melatonin production by affecting NAT. Although progesterone has been shown 
to decrease protein synthesis in the pineals of ovariectomized rats (Cardinali and Vacas, 1978) 
it does not seem to affect the rise in NAT activity which depends on synthesis of NAT 
molecules" (Daya, 1982). 
1.10.3.3 Castration and Testosterone 
Castration affects both the biochemistry and morphology of the pineal gland. The nocturnal 
rise of pineal NAT activity is depressed by castration (pavlinov and Isachenkov, 1979; 
Rudeen and Reiter, 1980). An explanation for this is that castration decreases the pineal 
concentration of cAMP. Cyclic AMP is essential for the induction of NAT, thus a decrease 
in cAMP in the pineal results in a decrease in NAT activity (Karasek et aZ., 1978). 
Testosterone restores the nocturnal rise in NAT activity in castrated animals, which indicates 
that this hormone influences NAT activity (Rudeen and Reiter, 1980). The maintenance of 
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cAMP S'-AMP 
FIGURE 1.6 The sequential activation of adenylate cyclase and cAMP-phosphodiesterase 
(PDE) in response to cQl+ inflUX through the plasma membrane and into the 
cytoplasm (Adapted from Cheung, 1982; Brown, 1992). 
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the diurnal rhythm has also been linked to the action of testosterone on the pineal gland by 
Daya (1982), who proposed that testosterone affected the release or synthesis of nor-
adrenaline by the sympathetic nerves of the pineal gland. 
1.10.3.4 Prostaglandins 
Recent studies have suggested that prostaglandins may playa role in the regulation of NAT 
(Ritta et al., 1981). a-Adrenergic receptor stimulation of pineal gland explants resulted in 
a release of prostaglandin ~ (Cardinali and Vacas, 1987). Prostaglandin synthesis inhibitors 
were found to block the nocturnal rise in NAT activity, and in vitro prostaglandin ~ 
increased pineal NAT activity (Cardinali and Vacas, 1987). 
1.10.4 Effect of Pineal Indoles on NAT Activity 
The synthesis of melatonin from tryptophan occurs for the greater part in darkness. Only the 
synthesis of serotonin is high during the daytime and low during darkness (pellegrino de 
Iraldi and Rodriguez de Lores Arnaiz, 1964; Snyder et al., 1965b). Thus, serotonin 
concentrations during the daytime are crucial for the amount of N-acetylserotonin synthesised 
by NAT during the night (Quay, 1963). The daytime concentration of serotonin has a dual 
function. Firstly, serotonin serves as the substrate for the synthesis of N-acetylserotonin 
which will ultimately be converted into melatonin. Secondly, serotonin exerts an inhibitory 
effect on nor-adrenaline induced activation of adenylate cyclase, thus having an indirect 
inhibitory effect on NAT activity and its own synthesis (Balemans, 1979). 
Bade and co-workers (1977) demonstrated that the inhibition of daytime monoamine oxidase 
increased nocturnal serotonin levels. These high levels of serotonin were found, in turn, to 
increase nighttime NAT activity, suggesting an enzyme-substrate related regulatory 
mechanism for NAT. The opposite was shown by King et al. (1982), who demonstrated that 
low levels of serotonin enhanced nocturnal and agonist-stimulated NAT activity. 
Tryptophan administrations increase serotonin levels in rat pineal glands (Snyder et aI., 
1965b). These administrations have also been shown to inhibit normally elevated nocturnal 
NAT activity (King et al., unpublished results). Enzyme kinetic studies (enzyme-substrate 
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interactions) have demonstrated that the enhanced levels of serotonin caused by the 
administration of tryptophan play no part in the tryptophan inhibition of NAT. Further 
studies showed that the blocking of serotonin receptors with cyproheptadine HCl blocked the 
tryptophan induced inhibition of NAT activity. This suggests that NAT inhibition by high 
concentrations of serotonin is receptor mediated and not substrate related (King et al., 
unpublished results). 
Melatonin treatment of rats was initially found to partially counteract the light-induced 
depletion of pineal lipids (Ebels and Prop, 1965; Fiske and Huppert, 1978). Subsequent 
investigation showed that melatonin increases the activity of the pineal enzymes, NAT and 
HIOMT, in a dose-dependant manner, revealing the lack of a feedback inhibition mechanism 
to melatonin (Cardinali and Wurtman, 1972). 
The other pineal gland indoles have, as yet, not been shown to exhibit direct effects on NAT 
activity. 
1.10.5 External Factors Affecting NAT Activity 
1.10.5.1 Drugs 
Stimulation of the sympathetic nerves and/or post-synaptic p-adrenergic receptor innervating 
the pineal gland is essential for pineal NAT activity. The neurotransmitter nor-adrenaline is 
involved in this action. The administration of any analogue of nor-adrenaline will result in 
an increase in NAT activity. The drug most used in pineal research in this regard is 
isoproterenol. Likewise, a compound such as desmethylimipramine, which blocks the uptake 
of nor-adrenaline from the synaptic space, effects an increase in NAT activity (Moyer et al., 
1979). Pargyline, a compound that prevents the inactivation of nor-adrenaline by inhibiting 
monoamine oxidases, also causes an increase in NAT activity (Deguchi and Axelrod, 1972b; 
Mata et al., 1976). 
Recent work by Attia et al. (1990 and 1991b) has shown that lindane, a chlorinated 
hydrocarbon pesticide, enhances the nighttime rise in NAT activity. Lindane's site of action 
was shown to be the pineal p-receptor. This site of action was elucidated with experiments 
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involving propranolol, a specific {1-receptor blocker, in the presence of lindane. Propranolol 
blocked the stimulatory effect of lindane, pointing to lindane's {1-receptor specificity. 
Further work by Attia et al. (l991a) on carbamate insecticides showed that carbaryl also 
increased NAT levels in the pineal gland and had a similar mode of action to that of lindane. 
Drugs known to decrease NAT activity are those such as propranolol, which block {1-
receptors. Compounds such as cycloheximide, that block protein synthesis, also result in a 
decrease in NAT activity by preventing the synthesis of the enzyme (Deguchi and Axelrod, 
1972b; Klein, 1979). Depolarising drugs, such as ouabain, also inhibit the induction of NAT 
activity by blocking the transmission of the neural impulse from the sympathetic nerves to the 
pinealocytes (parfitt et al., 1975). 
1.10.5.2 Stress 
Stress causes a minor increase in NAT activity (Lynch et al., 1973; Klein, 1979). In the 
presence of catecholamine re-uptake blockers, stress raises NAT activity to levels equivalent 
to those seen at night (parfitt and Klein, 1976; Vaughan et al., 1978). 
1.10.5.3 Photoperiods 
The effect of photoperiods on pineal NAT activity are considerable. As previously discussed 
in § 1.10.1, exposure of animals to light at night results in a rapid decrease in NAT activity 
(Klein and Weller, 1970; Alphs et al., 1980). This decrease is probably due to a cessation 
of nor-adrenaline release, the uptake of extracellular nor-adrenaline and the dissociation of 
nor-adrenaline from the {1-adrenergic receptors, which result in a decrease in cAMP 
production and inactivation of the enzyme (parfitt et al., 1975). 
1.10.6 Effect of Purine Nucleotides on NAT Activity 
In the pinealocyte, nucleotide concentrations are primarily controlled by the rate of synthesis 
(neural stimulation affecting synthesis) and the rate of degradation. 
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The most abundant neurotransmitter released from the nerves innervating the pineal gland is 
nor-adrenaline. The release of nor-adrenaline has been shown to exhibit a circadian rhythm, 
with highest release during the dark (Pellegrino de Iraldi and Zieher, 1966; Wurtman and 
Axelrod, 1966). Nor-adrenaline acts on ac, a2-, {3c and {32-adrenergic receptors, but shows 
more selectivity for ac and {3I-receptors (Ariens et al., 1979; Fain and Garcia-Sainz, 1980). 
Both receptor types have been fully characterised and shown to play an important role in 
cAMP, guanosine 3' ,5'-monophosphate (cGMP) and NAT synthesis (Auerbach et al., 1981; 
Klein et al., 1983; Sugden and Klein, 1984; Vanecek et al., 1985). 
1.10.6.1 Cyclic AMP 
The binding of {3-receptor agonists to {3-receptors results in an approximately 10 fold increase 
in cAMP concentration. The increase in cAMP occurs as a result of the activation of 
adeny1ate cyclase, a membrane bound enzyme, which converts ATP to cAMP in a process 
involving the hydrolysis of pyrophosphate. The activity of adeny1ate cyclase has been shown 
to be influenced by age, sex and environmental lighting (Strada et al., 1972). 
Nor-adrenaline has been shown to act via both aI- and {3-receptors. Where both receptors 
are stimulated, the cAMP concentration is increased between 30 and 100 fold. at-Receptor 
stimulation alone was found to elicit no change in cellular cAMP concentrations. Thus, it may 
be concluded that aI-receptor stimulation potentiates {3-receptor stimulation of pineal cAMP 
(Klein, 1985; Reiter, 1991). A peak in cAMP concentration is reached about five to 15 
minutes after {3-receptor stimulation. This peak is sustained for a period of approximately 
30 minutes (Deguchi, 1973). The eventual decrease in cAMP concentration is not related to 
the continued presence or absence of {3-receptor agonist, but rather to a decrease in adeny1ate 
cyclase activity (Klein et al., 1978; Vanecek et al., 1985). 
The pineal gland is a rich source of cAMP-dependent protein kinase. The elevated cAMP 
levels result in the activation of protein kinase. The protein kinase, in turn, causes the 
phosphorylation of other cellular proteins responsible for protein synthesis, resulting in the 
synthesis of NAT (Morrissey and Lovenberg, 1978; Benfenati et al., 1986; Reiter, 1991). 
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Cyclic AMP is inactivated by the enzyme pineal cAMP-phosphodiesterase. The enzyme's 
activity is influenced by intracellular calcium concentrations (Brown et al., 1989a and 1989b). 
The net result of increased intracellular concentrations of cAMP is an increase in NAT 
activity. 
1.10.6.2 Cyclic GMP 
Cyclic GMP and cAMP are controlled by a similar mechanism (Vanecek et al., 1985). The 
difference in their regulation is found at the site of control. Regulation of cAMP is post-
synaptic, while cGMP is regulated pre-synaptically (O'Dea and Zatz, 1976; Zatz and O'Dea, 
1977). 
The role of cGMP in the regulation of pineal function remains to be determined. It has been 
proposed that intracellular cGMP may complement or counteract the effects of cAMP (Strada 
et al., 1976). Thus, cAMP may be responsible for the activation of NAT and, by another 
mechanism, cGMP may counteract that activation. 
A study by Wilkinson (1976) suggests that NAT induction can be inhibited by the addition 
of dibutyryl cGMP. However, these findings have not been independently verified. 
Stimulation of pre-synaptic a-receptors has been shown to inhibit nor-adrenaline release in 
the pineal (pelayo et al., 1977). The administration of dibutyryl cGMP also inhibits nor-
adrenaline release (Pelayo et al., 1978). Thus, cGMP may be involved in the regulation of 
pineal pre-synaptic function (O'Dea and Zatz, 1976). 
1.10.7 Effect of Lipids and Amino Acids on NAT Activity 
1.10.7.1 Lipids 
Lipids, of which more than half are phospholipids, form between 3% and 10% of the wet 
weight of the pineal gland. Pinealocyte phospholipids have thus far been shown to exhibit 
an indirect effect on NAT activity. 
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Nordio et aZ. (1989) showed that phosphatidylserine stimulated NAT activity. The 
mechanism for this stimulation is thought to take place via stimulation of the aI-adrenergic 
receptor (Nordio et aZ., 1989). 
Nor-adrenaline stimulation of ,8-receptors on the pinealocyte cell surface results in an 
increased intracellular cAMP concentration which in turn induces NAT activity. aI-Receptor 
stimulation by nor-adrenaline has been shown to potentiate the above effect (Klein, 1985; 
Reiter, 1991), which is thought to take place via the activation of a phosphodiesterase to 
generate diacylglycerol and inosital phosphate, with the former activating protein kinase C 
(Berridge, 1986). Essential co-factors for protein kinase C activation are calcium and 
phosphatidy1serine. Protein kinase C has been implicated in many processes including 
phosphorylation of proteins essential for pinealocyte protein synthesis, thereby influencing 
NAT synthesis (Bazzi and Nelsestuen, 1987). 
Phospholipids have also been shown to exert an indirect effect on NAT through calcium. 
Diacylglycerol, formed by ai-receptor stimulation, is phosphorylated by a diacylglycerol 
kinase to form a phosphatidic acid which has been implicated as an ionophore to gate calcium 
across the plasma membrane (Putney et aZ., 1980). 
1.10.7.2 Amino Acids 
The most important amino acid affecting NAT activity is taurine. Taurine is synthesised from 
cysteine and is located entirely in the pinealocyte (Wheler et aZ., 1979). A daily rhythm in 
the concentration at the start of the dark period and peak levels during the middle of the light 
period have been shown (Grosso et aZ., 1978). 
Wheler and Klein (1979 and 1980) found that treatment of pineals with nor-adrenaline or ,8-
receptor agonists effected a large increase in the release of taurine, mediated by ,8-receptor 
and cAMP. 
High concentrations of taurine increase NAT activity. The stimulatory effect is blocked by 
propranolol, indicating that taurine is acting through ,8-adrenergic receptors (Wheler et aZ., 
1979). The functional importance of taurine is not currently clear. However, it is believed 
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that molecules of taurine released from the pinealocytes could interact with ~-receptors on 
the pre-synaptic, nor-adrenaline-containing, nerve terminals and thereby modify the release 
of nor-adrenaline (Klein et al., 1981). 
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CHAPTER II 
EXPERIMENTAL PROCEDURES 
2.1 Animals 
Adult male Wistar rats weighing between 200 and 250 g were used throughout the study. 
The animals were housed under artificial illumination with a daily photoperiod of 12 hours 
(lights on at 06hoo). The light intensity was approximately 300 W/cm2 provided by cool 
white fluorescent tubes. The animal-house temperature was maintained at a constant 20°C 
to 24°C and an extractor fan ensured the constant removal of stale air. The rats were 
housed three to four per cage with food and water ad libitum. 
When required, rats were sacrificed by neck fracture and decapitated. The brain was exposed 
by making an incision through the bone on either side of the parietal suture, from the foramen 
magnum to near the orbit and by removing the calvarium. The pineal glands were swiftly 
removed with sterile forceps and used in subsequent assays. 
For dark phase experiments, pineal glands were collected in a darkroom with the aid of a dim 
photo-safe red light (Phillips, 20W). Previous studies have shown that the activity of pineal 
enzymes sensitive to white light is not affected by red light (Cardinali et al., 1972). 
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2.2 Indole Metabolism by Pineal Organ Cultures 
2.2.1 Introduction 
The origins of organ culture may be traced back, over a hundred years, to Claude Bernard 
(1856) who stated that experimental techniques should be devised to allow previously invisible 
physiological occurrences to take place outside the body for man to witness (Brendel et al. , 
1987). 
The Strangeways Laboratory, some 60 years ago, was the first to practically implement the 
thoughts and ideas of Bernard through the culturing of embryonic rudiments (Strangeways and 
Fell, 1926; Fell and Robinson, 1929). Trowell (1959) successfully employed the organ 
culture technique to sustain fully differentiated organs or parts thereof, and introduced the 
concept of stabilizing the culture medium's alkalinity by including 5% carbon dioxide (CO:J 
with the oxygen (~). Using this technique, pineal glands were kept viable for a minimum 
period of six days (Klein, 1969). This technique has been modified by other investigators 
to suit their individual requirements. 
Pineal glands in culture are able to utilise radio-labelled precursors such as tryptophan, 5-
hydroxy tryptophan or serotonin, to synthesise various indole metabolites. 
Klein and Rowe (1970) and Skene (1985) showed that 95% of radioactive indoles synthesised 
from exogenous radio-labelled precursors are secreted out of the pineal gland into the culture 
medium. The radio-labelled indoles found in the culture medium may then be separated by 
employing bi-dimensional thin layer chromatography (TLC) and quantified by liquid 
scintillometry (Klein and Notides, 1969; Balemans et al., 1978). 
2.2.2 Materials and Method 
Animals: Male Wistar rats weighing between 200 and 250 g were used in these experiments 
and were maintained as described in § 2.1. The animals were sacrificed between 11hOO and 
11h30 during the daytime and between 23hOO and 23h30 during the nighttime. At night, the 
procedure was performed in a darkroom with the aid of a dim photo-safe red light. 
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Chemicals and Reagents: 5-Hydroxy [side chain-2-14C]-tryptamine creatine sulphate 
(specific activity 55 mCi/mmol) and L-[methyl-14C]-tryptophan (specific activity 54 
mCilmmol) were purchased from Amersham (England), synthetic pineal indoles from Sigma 
Chemical Co. (USA), aluminium TLC plates coated with silica gel 60 F254 (0.20 mm) from 
Merck (West Germany), BGJb culture medium (Fitton-Jackson modification) from Gibco 
(Europe) and Kimble glass organ culture tubes (10 x 75 mm) (USA). All other chemicals 
and reagents were purchased from local commercial sources. 
Pineal Gland Cultures: Wistar rats were sacrificed and the pineal glands rapidly removed 
according to the method described in § 2.1. The glands were cleaned of adhering connective 
tissue and individually placed into sterile organ culture tubes containing 52 ,al of BGJb 
medium. The BGJb medium was further supplemented with 0.06 mg/ml benzylpenicillin, 0.1 
mg/ml streptomycin sulphate and 2.5 ,ag/ml amphotericin B. The composition of the BGJb 
medium is shown in Table 2.1. To the 52 ,al of medium, 8 ,al of substrate (either P4C]_ 
serotonin or [14C]-tryptophan) was added. In the case of pharmacological manipulations, 
drugs were added in 5 and/or 10 ,al volumes to yield a final experimental volume of 70 ,al. 
The tubes were then aerated with carbogen (95% ~ : 5% COz) and sealed with Parafilm3 • 
The culture tubes containing the pineal glands were then placed in a dark incubator at 37°C 
for 24 hours. 
TLC Analysis: The TLC technique used is based on the method developed by Klein and 
Notides (1969). The culture tubes were removed from the incubator after the 24 hour 
incubation period and the reaction terminated by the removal of the glands from the medium. 
Ten microlitres of medium was removed from each tube and spotted onto a TLC plate (silica 
gel 60 F254, 0.20 mm x 10 cm x 10 cm aluminium plates). Following this, a solution 
containing synthetic unlabelled standards of all the pineal indoles was spotted on top of the 
culture medium spot. A total of 10 ,al of a solution containing 0.2 mg/ml of each standard 
was spotted. The indole standard solution was prepared as follows: 1 mg of each of the 
eight standards Oisted in Figure 2.1) were dissolved together in 2.5 ml of 95 % ethanol. To 
this, 2.5 ml of a solution of 1 % ascorbic acid in 0.1 N HCI was added. Klein and Notides 
(1969) included ascorbic acid in their standard to protect the indoles from oxidation. The 
pineal indole standards were stored, in the dark, at -20°C. The TLC plates were spotted 
under subdued light. 
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TABLE 2.1 The composition of BGJb culture medium (Fitton-Jackson modification). 
CONTENTS 
Amino Acids 
L-Alanine 
L-Arginine 
L-Aspartic Acid 
L-Cysteine HCI 
L-Glutamine 
Glycine 
L-Histidine 
L-Isoleucine 
L-Leucine 
L-Lysine HCI 
L-Methionine 
L-Phenylalanine 
L-Proline 
L-Serine 
L-Threonine 
L-Tryptophan 
L-Tyrosine 
DL-Valine 
Vitamins 
a-Tocopherol Phosphate 
Ascorbic Acid 
Biotin 
Calcium Pantothenate 
Choline Chloride 
Folic Acid 
Inosital 
Nicotinamide 
Para Aminobenzoic Acid 
Pyridoxal Phosphate 
Riboflavin 
Thiamine HCI 
Vitamin BIZ 
Inorganic Salts 
Dihydrogen Sodium Ortho Phosphate 
Magnesium Sulphate 7HzO 
Potassium Chloride 
Potassium Dibydrogen Phosphate 
Sodium Bicarbonate 
Sodium Chloride 
Other Components 
Calcium Lactate 
Glucose 
Phenol Red 
Sodium Acetate 
CONCENTRATION (mg/I) 
250.00 
175.00 
150.00 
90.00 
200.00 
800.00 
150.00 
30.00 
50.00 
240.00 
50.00 
50.00 
400.00 
200.00 
75.00 
40.00 
40.00 
65.00 
1.00 
50.00 
0.20 
0.20 
50.00 
0.20 
0.20 
20.00 
2.00 
0.20 
0.20 
4.00 
0.04 
90.00 
200.00 
400.00 
160.00 
3500.00 
5300.00 
555.00 
10000.00 
20.00 
50.00 
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MTOH 
MIAA HIAA HTOH 
DO 00 
f\ 
I U MEL 
HT = Serotonin 
MT = 5-Methoxytryptamine 
NAS = N-acetylserotonin 
MEL = Melatonin 
HIAA = 5-Hydroxyindoleacetic acid 
HTOH = 5-Hydroxytryptophol 
MIAA = 5-Methoxyindoleacetic acid 
MTOH = Methoxytryptophol 
(' 
~ NAS 
o Second Direction 
HT MT 
Ethyl Acetate 
First Direction (x2) 
Chloroform : Methanol : Acetic Acid 
(93 : 7 : 1) 
FIGURE 2.1 Diagrammatic representation of a 2-dimensional TLC plate showing the separation 
of pineal indoles. 
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A gentle stream of nitrogen was used to dry the spots, which were no larger than 0.5 cm, to 
protect the indole metabolites from atmospheric oxidation. Klein and Notides (1969) 
proposed the spotting and running of the plates in the dark to protect the indoles. Morton and 
Potgieter (1982) found no differences between plates spotted and run in normal light and 
dark. Each spotted plate was then placed in a TLC tank and developed twice, in the same 
direction, with solvent A composed of chloroform: methanol: acetic acid (93 : 7 : 1). The· 
solvent front was allowed to advance 8 cm up the plate, whereupon the plate was removed 
from the tank and dried under a stream of nitrogen. Once dry, the plate was placed back into 
the same tank and allowed to develop in the same direction for a second time. Following 
this, the plates were dried under a stream of nitrogen, rotated 90° and placed into a second 
TLC tank containing solvent B (ethyl acetate). This time the solvent was allowed to advance 
to a height of 6 cm. The plates were removed from the tank, dried again with nitrogen, and 
sprayed with Van Urk's reagent (l g of 4-dimethylaminobenzaldehyde dissolved in 50 mlof 
25% HCl, followed by the addition of 50 ml of 95% ethanol). After spraying, the plates 
were dried in an oven at 60°C for 20 minutes to visualise the spots. The spots were then cut 
out and placed individually into plastic scintillation vials containing 1 ml of absolute ethanol 
and allowed to stand. After five minutes, 3 ml of Ready-Solv HP scintillation cocktail was 
added to each vial, whereafter the vials were shaken for 15 minutes and the radioactivity 
quantified by liquid scintillometry. 
2.2.3 Results 
A bi-directional thin layer chromatogram of the indoles is presented in Figure 2.1. Two 
pineal indoles, namely serotonin and 5-methoxytryptamine, were found to remain at the 
origin. 
2.2.4 Discussion 
Banoo (1991) showed that unlabelled indole standards exerted no significant interference on 
the radioactive counts of the labelled indoles. The values of the standards were similar to the 
blank value and accounted for between 0.02% and 0.05% of the total radioactivity present. 
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2.3 Pineal Serotonin N-Acetyltransferase Activity Assay 
2.3.1 Introduction 
Serotonin N-acetyltransferase (NAT) (BC 2.3.1.87) is the enzyme responsible for the 
conversion of serotonin to N-acetylserotonin, the precursor of melatonin. This conversion 
of serotonin to N-acetylserotonin has often been referred to as the rate-limiting step in 
melatonin synthesis (Klein et ai., 1981; Reiter, 1991). 
The exact mechanism by which NAT is regulated is still unknown. The main reason for this, 
is the inability of the enzyme to be purified without losing its activity. Research has shown 
that the enzyme is affected by many factors, such as: light, stress, hormones, proteins, 
inorganic constituents and drugs, to name but a few. 
The cascade effect produced by p-receptor stimulation has been shown to be the primary 
route for NAT regulation. The cascade effect occurs as follows: nor-adrenaline is released 
in relatively large quantities at night by the sympathetic nerves innervating the pineal gland. 
Nor-adrenaline binds to the p-receptors, resulting in the activation of a membrane-bound 
enzyme, adenylate cyclase, which converts ATP to cAMP (Deguchi and Axelrod, 1975). The 
increased intracellular cAMP concentration activates phosphorylating enzymes and proteins. 
These, in turn, promote protein synthesis, resulting in the de novo synthesis of NAT. 
As a result of its "rate-limiting status", NAT is often used as a measure of pineal activity. 
The most commonly used assay method for this enzyme was developed in 1972 by Deguchi 
and Axelrod. This method was modified by Champneyet ai. (1984), and this modification 
has been used in all subsequent experimental work. 
The principle of the assay is based on the acetylation of tryptamine (substrate) with radio-
labelled acetyl coenzyme A by endogenous pineal NAT, to form a radio-labelled product, N-
acetyltryptamine. The radio-labelled N-acetyltryptamine formed is then extracted into an 
organic solvent and quantified by liquid scintillometry. 
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2.3.2 Materials and Method 
Animals: Male Wistar rats weighing between 200 and 250 grams were used in these 
experiments. The animals were maintained as described in § 2.1. The animals were 
sacrificed between 11hoo and 11h30 during the daytime and between 23hoo and 23h30 during 
the nighttime. At night this was performed in a darkroom with the aid of a dim photo-safe 
red light. 
Chemicals and Reagents: [14C]-Acetyl coenzyme A (specific activity 4.0 mCi/mmol) was 
purchased from Dupont Chemical Co. (USA). Tryptamine HCI and I-isoproterenol were 
purchased from Sigma Chemical Co. (USA). Unlabelled acetyl coenzyme A was purchased 
from Merck (West Germany). All other chemicals and reagents were purchased from local 
sources. 
Buffer Solutions: 
a) The phosphate buffer was prepared as follows: 
Solution A: 1.19 g of Na2HP04 ·2H20 was dissolved in 100 ml of distilled water. 
Solution B: 908 mg of KH2P04 was dissolved in 100 m1 of distilled water. 
Solution C: 49.2 ml of solution A and 50.8 ml of solution B were added together 
to give a phosphate buffer with pH 6.8. 
b) The borate buffer was prepared as follows: 
Solution A: 746 mg of KCl and 620 mg of H3B03 were dissolved in 100 ml of 
distilled water. 
Solution B: 50 m1 of solution A was then adjusted to pH 10 using 0.1 N NaOH. 
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Working Solution: The working solution, as shown in Table 2.2, contained 5.6 mM 
tryptamine HCl, 800 JLM acetyl coenzyme A, 40 nCi [14C]-acetyl coenzyme A and chilled 
phosphate buffer pH 6.8 in a final volume of 10 JLl, per sample. The working solution was 
prepared immediately before the assay and kept chilled on a bed of crushed ice. 
TABLE 2.2 Scheme of NAT working solution. 
REAGENTS 
Tryptamine HCl (5.6 mM) 
Acetyl Coenzyme A (800 JLM) 
[ 14C]-Acetyl Coenzyme A (40 nCi) 
Phosphate Buffer 
Total Volume 
VOLUME (",Usample) 
5 
2 
2 
1 
10 
Assay Procedure: Rats were sacrificed by neck fracture and the pineal glands rapidly 
removed. Each pineal was individually placed into a small glass homogeniser containing 100 
JLl of ice-cold 50 mM phosphate buffer pH 6.8 and homogenised for 30 seconds. 
The assay was carried out, in duplicate, in 1 500 JLl Eppendorf microfuge tubes. 
Homogenates (20 JLl aliquots) from each pineal gland were transferred to the bottom of the 
microfuge tubes. A 10 JLl aliquot of working solution was then pipetted onto the side of each 
tube. The surface tension was adequate in keeping the working solution, on the side of the 
tube, and the pineal homogenate, at the bottom of the tube, separate. Once all tubes had been 
properly prepared, they were tapped on the work bench which caused a mixing of the 
working solution and pineal homogenate. The tubes were further vortexed to ensure proper 
mixing. The tubes were then incubated at 37°C in a shaking water bath for 20 minutes. 
Blank incubations were performed in which only the enzyme (NAT in pineal homogenate) 
was omitted. 
After incubation, the reaction was terminated by the addition of 100 JLl of ice-cold borate 
buffer pH 10 to each tube. The radio-labelled N-acetyltryptamine formed was extracted by 
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the addition of 1 ml of toluene : isoamyl alcohol (97 : 3) to each tube. The tubes were 
shaken for five minutes and the resultant emulsion was centrifuged at 4 500 rpm for 30 
seconds. The tubes were again opened and washed with a second 100 ,al aliquot of ice-cold 
borate buffer, shaken and centrifuged. A 0.5 m1 aliquot of the organic phase from each tube 
was transferred to plastic scintillation vials containing 3 m1 of scintillation cocktail (Ready-
Solv HP, Beckman, USA) and the radioactivity quantified by liquid scintillometry. 
Calculation of NAT Activity: The results of the NAT assay are expressed as NAT 
activity/pineal gland/hour. 
where: 
(DPMsampie - DPMblanJ x m x p x 2 x 3 = pmol NAT Activity 
DPMtotal pineal gland/hour 
m = fraction of pineal homogenate assayed (l for whole pineal i.e. 100,a1; 
5 for 20 ,al etc), 
p = pmoles of acetyl coenzyme A per sample, 
2 = factor for counting only half the toluene : isoamyl alcohol used for the 
extraction of P4C]-N-acetyltryptamine, and 
3 = factor for incubating the sample for 20 minutes (Khan, 1989). 
In Vitro Studies: For in vitro studies of NAT activity, groups of five pineal glands were 
incubated in sterile 12 mm glass culture tubes containing 300 ,al of BGJb culture medium. 
Alternatively, pineals were incubated individually in sterile glass tubes containing 60 ,al of 
BGJb medium. In either case, a 10 ,al aliquot of test drug or compound, was added to each 
tube. The tubes were incubated at 37°C in a humidified atmosphere of 95% O2 and 5% CO2 
for a specified time period. Following incubation, the glands were removed, homogenised 
and the enzyme activity assayed as described above. 
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2.4 Pineal Cyclic AMP Assay 
2.4.1 Introduction 
A variety of techniques have been employed to measure cAMP levels. Early assay techniques 
involved the measurement of adenylate cyclase activity as an index of cAMP levels (Krishna 
et al., 1968). 
Gilman (1970) developed the first direct assay method, using a purified protein from bovine 
muscle. Brown et al. (1971) developed a saturation assay for cAMP, using purified bovine 
adrenal proteins as the specific binding protein. This binding protein had been identified 
earlier by Gill and Garren (1969) as a protein kinase. 
The saturation assay involves the incubation of tissue sample together with binding protein 
and tritiated cAMP. Competition arises between endogenous cAMP and the tritiated cAMP 
for the binding sites on the binding protein. The binding protein is later separated and 
counted. A standard cAMP curve is generated for each experiment, from which the 
endogenous cAMP of the tissue sample is determined. 
2.4.2 Materials and Method 
Animals: Male Wistar rats weighing between 200 and 250 g were used in these experiments. 
The animals were sacrificed between 11hoo and 11h30 during the daytime and between 23hoo 
and 23h30 during the nighttime. At night, the procedure was performed in a darkroom with 
the aid of a dim photo-safe red light. 
Chemicals and Reagents: [8-3H]-Adenosine 3' ,5' -cyclic phosphate, ammonium salt (specific 
activity 30 Ci/mmol) was purchased from Amersham (England). Standard cAMP was 
purchased from Boehringer Mannheim (West Germany). Theophylline was purchased from 
Sigma Chemical Co. (USA) and activated charcoal from Merck (West Germany). All other 
chemicals and reagents were purchased from local sources. 
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Preparation of cAMP Binding Protein: Bovine adrenal glands were collected from freshly 
slaughtered animals and transported on ice to the laboratory. The glands were stripped of 
adhering tissue and the medullas discarded. The adrenal cortices were homogenised in 1.5 
volumes of an ice-cold medium comprising 0.25 M sucrose, 50 mM Tris-HCI buffer pH 7.4, 
25 mM potassium chloride and 5 mM magnesium chloride. The homogenate was centrifuged 
at 2 000 g for 15 minutes at 4°C. The supernatant was re-centrifuged at 5000 g for 15 
minutes at 4°C. The resultant supernatant was stored in 0.5 ml aliquots at -20°C. The 
preparation was thawed and diluted as required with 50 mM Tris-HCI buffer pH 7.4 
containing 8 mM theophylline and 6 mM 2-mercaptoethanol. 
Preparation of Pineal Tissue: Male Wistar rats were sacrificed and the pineal glands rapidly 
removed. The pineals were dissected free of adhering connecting tissue and placed 
individually into 100 III of ice-cold phosphate buffer pH 6.8. The pineal glands were 
homogenised and 50 III of the homogenate was used for cAMP determination. 
Cyclic AMP Assay Procedure: The assay was carried out according to the scheme 
represented in Table 2.3. Briefly, the assay was carried out in 1.5 ml Eppendorf microfuge 
tubes containing known amounts of standard cAMP (0 - 8 pmol/assay tube) or 50 III of 
sample, 100 III of diluted binding protein and 50 mM Tris-HCL buffer pH 7.4 containing 8 
mM theophylline and 6 mM 2-mercaptoethanol, to a final volume of 350 Ill. The tubes were 
gently agitated and then placed on ice at 4°C for 100 minutes. After incubation, 100 III of 
a 10% w/v suspension of charcoal in buffer containing 2% w/v bovine serum albumin was 
added to each reaction tube. The tubes were vortexed for 10 seconds each and then 
centrifuged at 1 200 g for 15 minutes at 4°C. A 100 III aliquot of the supernatant was 
removed from each tube and placed into a plastic scintillation vial containing 3 ml of Ready-
Solv HP (Beckman, USA) scintillation fluid. The vials were agitated and the radioactivity 
quantified by means of liquid scintillometry in a Beckman LS 2500 scintillation counter at an 
efficiency of 60 % - 65 % . Counting efficiency was determined by external channel ratio 
method of quench correction. A correction factor was built into the quench correction 
program to allow for tritium decay. A calibration curve was plotted in terms of standard 
concentration of nucleotide (pmol) against the Co/Cx ratio. The Co/Cx ratio is obtained by 
dividing the radioactivity (cpm) of the zero standard (Co) by the radioactivity of the higher 
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TABLE 2.3 Scheme of the cyclic AMP assay. 
• 
CYCLIC AMP STANDARDS (pmol) 
REAGENTS (PI) BLANK 0 0.25 0.5 1.0 2.0 4.0 8.0 SAMPLE 
Buffer* 250 150 150 150 150 150 150 150 150 
Standard --- --- 50 50 50 50 50 50 50 
Sample --- --- --- --- --- --- --- --- 50 
eRJ-cAMP 50 50 50 50 50 50 50 50 50 
Diluted Protein --- 100 100 100 100 100 100 100 100 
INCUBATE ON ICE FOR 100 MINUTES 
Charcoal 100 100 100 100 100 100 100 100 100 
CENTRIFUGE AT 1200 g FOR 15 MINUTES AT 4°C 
Supernatant 100 100 100 100 100 100 100 100 100 
ADD TO 3 ml SCINTILLATION FLUID AND COUNT RADIOACTIVITY 
Tris-HCl (50 mM, pH 7.4) containing 8 mM theophylline and 6 mM 2-
mercaptoethanol 
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standards (ex) after subtraction of the blank value. The amount of unknown cAMP in the 
samples was determined with reference to the standard curve in each assay. 
2.4.3 Results 
Dilution of Binding Protein: Serial dilutions of binding protein in 50 mM Tris-Hel buffer 
pH 7.4 containing 8 mM theophylline and 6 mM 2-mercaptoethanol were prepared according 
to the scheme reflected in Table 2.4, together with the general method of cAMP assay 
explained in § 2.4.2. Each dilution was assayed in duplicate and the radioactivity (cpm) 
plotted against the dilution. 
TABLE 2.4 Binding protein dilution curve protocol. 
• 
REAGENTS 
rH]-cAMP 
Standard cAMP 
Diluted Binding Protein 
Buffer· 
Total Volume 
VOLUME (pI) 
50 
50 
100 
150 
350 
Tris-Hel buffer (50 mM, pH 7.4) containing 8 mM theophylline and 6 mM 2-
mercaptoethanol. 
The results obtained from the dilution curve (Figure 2.2) showed that a 1 : 9 dilution with 
assay buffer provided adequate binding. In all subsequent cAMP assays, a dilution of 1 : 9 
for the binding protein was used. Each time a new batch of binding protein was prepared, 
a new dilution curve was determined. 
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Standard cAMP Curve: The standard curve was plotted in terms of concentration of 
nucleotide (pmolltube) against the Co/Cx ratio, where: 
Co = cpm zero standard - cpm blank and 
Cx = cpm standard - cpm blank. 
The result was a linear standard curve between 0 and 8 pmol cAMP (Figure 2.3, linear 
regression analysis, .r2 = 0.998). 
Interference by Non-cAMP Material: The sensitivity of a saturation assay method is 
influenced by a number of factors, the most prominent being interference by non-cAMP 
material. To test the extent of this interference, pineal tissue homogenates were incubated 
with commercially purchased phosphodiesterase (Boehringer Mannheim) for one hour at 37°C 
to destroy cAMP. Samples incubated without phosphodiesterase acted as controls. The 
results showed no significant difference between the samples incubated with or without 
phosphodiesterase, indicating that interference by non-cAMP material is negligible in this 
assay. 
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FIGURE 2.3 Cyclic AMP standard curve. 
Each point represents the mean of duplicate determinations (rZ = 0.998). 
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2.5 Pineal Cyclic AMP-Phosphodiesterase Assay 
2.5.1 Introduction 
Cyclic nucleotides play an important role in the control of intracellular events, and their 
concentrations are delicately regulated (Teo et al., 1973). These intracellular concentrations 
are primarily controlled by the rate of synthesis and degradation of the nucleotides. 
Degradation is catalysed by phosphodiesterase enzymes which hydrolytically cleave the cyclic 
nucleotides. 
Phosphodiesterase was first discovered by Sutherland and Rall (1958). The enzyme was 
partially purified from bovine heart in 1967 by Butcher and Sutherland. The activity of the 
enzyme was found to be dependent on the presence of an activator protein (Cheung, 1970; 
Kakiuchi et aI., 1970). This protein was later named calmodulin (Cheung, 1980). 
Calmodulin has been termed "a universal receptor of the Ca2+ signal" in cells by Klee and 
Haiech (1980) due to its ability to be modified by intracellular calcium concentrations. Drugs 
have been shown to affect phosphodiesterase activity through modification of calmodulin 
activity. 
The separation of cyclic nucleotides from their nucleosides has been shown to be easier than 
separating them from their monophosphate precursors. A number of methods, including 
batch or column anion-exchange resins (Thompson and Appleman, 1971; Lynch and Cheung, 
1975), paper chromatography (Nakai and Brooker, 1975), precipitation (LeDonne and Coffee, 
1979) and TLC (Neuman, 1983), have been developed to monitor phosphodiesterase activity. 
In this study the TLC method developed by Neuman (1983) was used. 
2.5.2 Materials and Method 
Animals: Male Wistar rats weighing between 200 and 250 g were used in these experiments 
and were maintained as described in § 2.1. The animals were sacrificed at 11hOO during the 
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daytime and at 23hoo during the nighttime. At night the procedure was performed in a 
darkroom with the aid of a dim photo-safe red light. 
Chemicals and Reagents: [8-3H]-Adenosine 3' ,5'-cyclic phosphate, ammonium salt (specific 
activity 30 Ci/mmol) was purchased from Amersham (England). Phosphodiesterase (BC 
3.1.4.17, specific activity ca 0.31 U/mg), adenosine 3' ,5'-cyclicphosphate and adenosine 5'-
monophosphate were purchased from Boehringer Mannheim (West Germany). TLC plates 
(Alugram Sil G/UV254 , 0.025 x 20 x 20 cm) were purchased from Macherey-Nagel (West 
Germany). All other chemicals and reagents were purchased from local sources. 
Assay Procedure: The assay was performed according to the scheme represented in Table 
2.S. Rats were sacrificed by neck fracture and the pineal glands rapidly removed. The 
glands were cleaned of adhering connective tissue and placed individually into glass 
homogenisers containing 1oo,u1 of Tris-HCI buffer (40 ,uM, pH 8 containing 5 ,uM MgCI~. 
The glands were homogenised for 30 seconds (approximately 15 strokes). Duplicate 10 ,ul 
aliquots of each pineal homogenate were transferred to reaction vessels containing 10 ,ul 
cAMP (1 ,uM), 10 ,ul eH]-cAMP and 20 ,ul buffer. The blank contained all the above 
mentioned reagents with the exception of the- pineal homogenate. The tubes were then 
incubated at 37°C for 30 minutes. The reaction was terminated by the addition of 30 ,ulof 
10% trichloroacetic acid, and the eH]-5'-AMP formed was separated from the remaining 
[3H]-cAMP by TLC. 
Thin Layer Chromatography: Ten microlitre aliquots of each sample were spotted 15 mm 
from the bottom of the plates. Standard solutions containing 0.2 mg/ml authentic cAMP or 
5' -AMP dissolved in distilled water were spotted at the ends of the plate in order to monitor 
the mobility of cAMP and 5'-AMP in the samples. The plates were developed once with an 
ascending solvent front composed of isopropylalcohol : 25% water of NH..OH : water (7 : 
1 : 2). Following development, the plates were dried under a stream of nitrogen. The spots 
were visualized under short wave ultraviolet light and the radioactivity collected by scraping 
each spot into a separate plastic scintillation vial containing 400 ,ul 0.01 M KOH and 3 ml 
of scintillation cocktail (Ready-Solv HP, Beckman, USA). The vials were shaken for 20 
minutes and the radioactivity quantified in a Beckman LS 2800 scintillation counter. 
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TABLE 2.5 Scheme of cAMP-phosphodiesterase assay (Neuman, 1983). 
REAGENTS {JLl} SAMPLE BLANK 
Pineal Gland Homogenate 10 ---
cAMP 10 10 
[3H]-cAMP 10 10 
Buffer· 20 30 
INCUBATE AT 37°C FOR 30 MINUTES 
Trichloroacetic Acid 30 30 
(10%) 
REMOVE 10 JLI FROM EACH TUBE FOR TLC 
• Tris-HCI Buffer (40 ,uM, pH 8) containing 5 ,uM MgC12 
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2.5.3 Results 
Figure 2.4 illustrates the hydrolysis of cAMP by phosphodiesterase with time. The 
hydrolysis of cAMP followed an almost linear fashion for the 30 minute period, resulting in 
the use of 30 minutes as the incubation time for the assay. The activity of phosphodiesterase 
is expressed as pmo1es of [3H]-5'-AMP formed per gland per hour. Blank values were found 
to be consistently less than 0.45% of the monitored radioactivity. 
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2.6 The Separation of Pineal Adenosine Nucleotides 
2.6.1 Introduction 
The separation of nucleotides, nucleosides and nucleic acid bases has been of interest to 
scientists for many decades. During the early to mid 1960's, thin layer chromatographic 
(TLC) methods were developed to separate and quantify these compounds. The advantages 
of these TLC techniques were the simplicity of use together with their sharp resolution and 
great sensitivity (Rand erath and Randerath, 1965). 
The separation of nucleotides was found to be most effective on anion-exchange layers. Of 
the many compounds tested, polyethyleneimine (PEI) cellulose was shown to have superior 
resolution and a versatile applicability. The migration of nucleotides on PEl-cellulose layers 
is affected predominantly by: the cellulose material, the amount of PEl used and the 
concentrations of aqueous electrolyte solutions used as solvents (Bohme and Schultz, 1967). 
In these studies the technique described by Bohme and Schultz (1967) was used. 
2.6.2 Materials and Method 
Animals: Male Wistar rats weighing between 200 and 250 g were used in this study and 
were maintained as described in § 2.1. The animals were sacrificed by neck fracture at 
11hoo. 
Chemicals and Reagents: [2-3H]-Adenosine (specific activity 26 Ci/mmol) was purchased 
from Amersham (England) . Unlabelled adenosine 5' -triphosphate, adenosine 5' -diphosphate, 
adenosine 5' -monophosphate and cyclic adenosine 3' , 5' -monophosphate were purchased from 
Boehringer Mannheim (West Germany). I-Isoproterenol and propranolol were purchased 
from Sigma Chemical Co. (USA). Plastic TLC plates (5 cm x 20 cm) coated with 
polyethyleneimine cellulose (polygram3 , Cel 300 PEI/UV254) 0.1 mm were purchased from 
Macherey-Nagel (West Germany). BGJb culture medium (Fitton-Jackson modification) was 
purchased from Gibco (Europe). All other chemicals and reagents were purchased from local 
commercial sources. 
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CHAPTERm 
RAT PINEAL GLAND INDOLEAMINE lVIETABOLISM 
3.1 Introduction 
The ability of the rat pineal gland to produce indole metabolites from exogenous precursors 
such as tryptophan, 5-hydroxytryptophan and serotonin was shown some 60 years ago 
(Strangeways and Fell, 1926). Based on this principle, Klein and Notides (1969) developed 
a method to examine the metabolism of indoles in pineal cultures. 
The advantages of this technique are that it: 
provides a quantitative picture of pineal indole metabolism, 
is sensitive to pharmacological manipulations (Klein and Rowe, 1970; Balemans et 
al., 1983; Voisin et al., 1983; Daya and Potgieter, 1985), and 
adequately reflects changes in pineal indole metabolism. 
In 1986, Daya and Fata were the first to describe a method which allowed the progressive 
measurement of indole formation in pineal glands over a 24 hour period. The advantages of 
this technique compared to that of Klein and Notides (1969) are that it: 
provides information on the progressive formation of indole metabolites at any stage 
of the culture period, and 
could indicate the ideal time to terminate the culture period (BartOO, 1991). 
Both methods have been used in subsequent studies to investigate the metabolism of [14C]_ 
tryptophan to its metabolites over a 24 hour period and the differences between serotonin and 
tryptophan metabolism. 
3.2 Experiment 1: 
3.2.1 Introduction 
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A 24 Hour ProrIle of [14C]_ Tryptophan Metabolism 
by Organ Culture of Rat Pineal Glands. 
Pineal organ culture assays have shown little deviation from the practical method described 
by Klein and Notides (1969). One of the variations to this method was that of Daya and Fata 
(1986), who were able to show the progressive metabolism of pineal indoles. This method 
was later used by Banoo et al. (1987) to describe the progressive formation of pineal indoles 
from p4C]-serotonin in the presence of l1-receptor agonist. 
The purpose of the present study was to investigate the effect of nor-adrenaline, the 
neurotransmitter found in the nerve terminals innervating the pineal gland, on the progressive 
metabolism of exogenous radio-labelled tryptophan to its radio-labelled metabolites. 
3.2.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1. The animals were sacrificed by neck fracture at IlhOO. 
Chemicals and Reagents: L-methyl-[14C]-tryptophan (specific activity 54 mCi/mmol) was 
purchased from Amersham (England) and nor-adrenaline from Sigma Chemical Co. (USA). 
All other chemicals and reagents were obtained from previously acknowledged sources (§ 
2.2.2). 
Organ Culture: After sacrifice, the pineal glands (n = 5) were rapidly removed and placed 
individually into sterile culture tubes containing BOTh medium, P4C]-tryptophan and 10 JotM 
nor-adrenaline (to a final volume of 70 Jotl) at 37°C in an atmosphere of 95 % O2 and 5 % CO2 
as previously described (§ 2.2.2). Control pineal glands (n = 5) were incubated in the 
absence of nor-adrenaline. At two-hourly intervals, 5 Jotl aliquots of culture medium were 
removed from each tube, the tubes being immediately replenished with an equivalent volume 
from an identical set of tubes containing no tissue. The indoles in the 5 Jotl aliquots were 
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isolated by two dimensional TLC and quantified by liquid scintillometry as described in § 
2.2.2. 
All data were statistically compared using Student's t test and expressed as dpm/5 Itl 
medium/pineal gland. 
3.2.3 Results 
The nor-adrenaline stimulated pineals showed a progressive increase in N-acetylserotonin and 
melatonin with peak levels being reached after 16 and 20 hours respectively (Figures 3.1 and 
3.2). The peaks reached in the nor-adrenaline stimulated pineals were significantly higher 
than those in the unstimulated controls (p < 0.05). N-acetylserotonin levels were 
significantly higher than melatonin levels in both stimulated and unstimulated pineals. 
When compared to the controls, the other indole metabolites, 5-hydroxyindoleacetic acid 
(HIAA), 5-hydroxytryptophol (HTOH) , 5-methoxyindoleacetic acid (MIAA) and 5-
methoxytryptophol (MTOH) progressively increased for 16 to 20 hours (Figures 3.3 to 3.6). 
From the onset of the experiment, HIAA was the only indole to show a sharp significant rise 
(p < 0.05) when compared with the control. As HIAA and HTOH levels increased with 
time (Figures 3.3 and 3.4), MIAA and MTOH levels were respectively found to decrease and 
remain constant compared with control levels (Figures 3.5 and 3.6). 
3.2.4 Discussion 
,8-Adrenergic receptor stimulation by nor-adrenaline, the neurotransmitter and ,8-receptor 
agonist found in the sympathetic nerves innervating the pineal gland, caused a marked rise 
in the synthesis of N-acetylserotonin and melatonin as compared with the unstimulated 
controls (Figures 3.1 and 3.2). The initial rise of N-acetylserotonin and melatonin was found 
to be gradual when compared with the results of Banoo et al. (1987). Using serotonin as the 
precursor in their experiments, Banoo et al. (1987) showed a rapid increase in N-
acetyl serotonin and melatonin synthesis within the first few hours of stimulation. 
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The higher N-acetylserotonin levels as compared with melatonin levels could be the result of 
changes in hydroxyindole-O-methyltransferase (HIOMT) activity. Nor-adrenaline stimulates 
tryptophan hydroxylase to convert tryptophan to 5-hydroxytryptophan (Wurtman et al., 1971; 
Shibuya et al., 1978). 5-Hydroxytryptophan is converted to serotonin which is acted upon 
by N-acetyltransferase (NAT) to form N-acetylserotonin. NAT activity increases between 
30- and 1oo-fold in the presence of .8-adrenergic receptor agonist (Klein and Berg, 1970; 
Klein et al., 1970; Klein et al., 1978). Thus, nor-adrenaline causes the production of vast 
quantities of N-acetylserotonin. On the other hand, HIOMT activity has been shown to be 
increased at a much slower rate than NAT (Klein and Berg, 1970; Sugden and Klein, 1983). 
As a result of a slow conversion of N-acetylserotonin to melatonin, a build-up of N-
acetyl serotonin could arise. 
The conversion of 5-hydroxyindoles to 5-methoxyindoles by HIOMT was limited in nor-
adrenaline stimulated pineals. This was probably due to substrate competition for the 
enzyme. The high levels of 5-hydroxyindoleacetic acid in nor-adrenaline stimulated pineals 
points to the possibility that its synthesis by monoamine oxidase (MAO) could be regulated 
via a .8-adrenergic receptor mechanism. 
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FIGURE 3.1 A 24 hour profile of tryptophan metabolism to N-acetylserotonin in nor-
adrenaline stimulated (---+---) and control ( 0 ) pineal glands 
(means + SEM, n = 5). 
* as compared with the control, p < 0.05, Student's t test. 
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FIGURE 3.2 A 24 hour profile of tryptophan metabolism to melatonin in nor-adrenaline 
stimulated (---+---) and control ( D ) pineal glands 
(means + SEM, n = 5). 
* as compared with the control, p < 0.05, Student's t test. 
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FIGURE 3.3 A 24 hour profile of tryptophan metabolism to 5-hydroxyindoleacetic acid in 
nor-adrenaline stimulated (---+--) and control pineal glands ( 0 ) 
(means + SEM, n = 5). 
* as compared with the control, p < 0.05, Student's t test. 
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3.3 Experiment 2: 
3.3.1 Introduction 
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Comparison of [14C]_ Tryptophan and rt4C]-Serotonin 
Metabolism by Organ Culture of Rat Pineal Glands. 
Pineal glands of rats housed under diurnal lighting conditions exhibit a diurnal rhythm in the 
synthesis of the pineal hormone, melatonin (Brownstein and Axelrod, 1974; Romero, 1976). 
This is effected by the release of nor-adrenaline at night from the sympathetic nerve terminals 
innervating the gland (Relkin, 1976). Nor-adrenaline, acting via the ,8-adrenergic mechanism, 
stimulates the activity of the pineal enzyme N-acetyltransferase (NAT) resulting in enhanced 
conversion of the high levels of serotonin accumulated during the day to N-acetylserotonin 
(NAS). NAS is subsequently converted to melatonin by the enzyme hydroxyindole-O-
methyltransferase (HIOMT). Consequently, the rat pineal concentrations of serotonin and 
melatonin follow an inverse relationship (Wurtman et al., 1968; Wolstenholme and Knight, 
1971; Axelrod, 1974; Quay, 1974a). 
It is well established that the rat pineal gland in organ culture is able to convert radio-labelled 
tryptophan to melatonin (§ 3.1). Serotonin formed as an intermediate in this pathway is acted 
upon by the enzyme monoamine oxidase (MAO) to produce a number of indole metabolites. 
There appear to be two distinct pools of serotonin in the pineal. One of these is the 
pinealocyte proper, which accounts for 30% of the MAO activity of the gland (Goridis and 
Neff, 1971), and the other is the nerve terminals of the fibres from the superior cervical 
ganglia, which accounts for 70% of the MAO activity of the gland (Goridis and Neff, 1971). 
In chick pineal glands, it has been shown that marked differences exist in the metabolism of 
tryptophan and serotonin (Wainwright, 1977). The major metabolite of serotonin metabolism 
is 5-hydroxyindoleacetic acid (HIAA) whereas the major metabolite of tryptophan metabolism 
is melatonin. 
The purpose of this study was to compare the metabolism of exogenous radio-labelled 
tryptophan and serotonin by organ culture of rat pineal glands. 
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3.3.2 Materials and Method 
Twenty four male Wistar rats weighing between 200 and 250 g were used in this experiment. 
The animals were maintained as described in § 2.1. The animals were sacrificed by neck 
fracture at IlhOO for the day study and at 23hOO for the night study. The collection of 
pineals for the night study was performed according to § 2.1. 
Chemicals and Reagents: L-methyl-p4C]-tryptophan (specific activity 54 mCi/mmol) and 
5-hydroxy [side chain-2-14C]-tryptamine creatine sulphate (specific activity 57 mCi/mmol) 
were purchased from Amersham (England). All other chemicals and reagents were obtained 
from previously acknowledged sources (§ 2.2.2). 
Organ Culture: The technique of pineal organ culture and the analysis of labelled indoles 
was performed as outlined in § 2.2.2. Briefly, after sacrifice, the pineal glands were swiftly 
removed and placed individually into sterile glass tubes each containing 60 ",1 BGJb culture 
medium in which either 0.4 ",Ci of e4C]-serotonin (n = 6) or 0.4 ",Ci of [14C]_tryptophan (n 
= 6) was present. The tubes were then incubated at 37°C for 24 hours in a humidified 
atmosphere of 95 % O2 and 5 % CO2• 
In the night study, animals were sacrificed in darkness, whereafter pineals were removed and 
placed in organ culture as described above. 
The incubation was terminated after 24 hours and 10 ",1 aliquots of culture medium were 
removed from each tube for analysis. The indo1es were isolated using TLC and quantified 
by liquid scintillometry as described in § 2.2.2. 
All data were statistically compared using Student's t test and expressed as the mean of six 
separate incubations + SEM. 
3.3.3 Results 
Tryptophan metabolism was similar in pineals removed during both the day and the night 
(Table 3.1). Melatonin formation by pineals removed during the dark phase was 
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approximately twice as great (p < 0.05) as that of pineals removed during the light phase 
(Figure 3.7). Contrary to expectations, N-acetylserotonin levels were slightly higher during 
the day study (Figure 3.8). 5-Hydroxyindoleacetic acid and 5-methoxyindoleacetic acid 
showed no significant difference between day and night studies (Figures 3.9 and 3.10). 
The metabolism of serotonin on the other hand yielded a significant difference between the 
day and night study (Table 3.2). Approximately six times more 5-hydroxyindoleacetic acid 
was synthesised by serotonin metabolism than by tryptophan metabolism. In addition, the 
percentage of melatonin and monoamine oxidase products formed from serotonin was greater 
than with tryptophan as the precursor. The metabolism of serotonin to melatonin, N-
acetyl serotonin and 5-hydroxyindoleacetic acid by pineals removed at night was significantly 
greater (p < 0.05) than by pineals removed during the daytime (Figures 3.11 to 3.13). 5-
Methoxyindoleacetic acid levels decreased in the night study compared with the day study, 
but not significantly (Figure 3.14). 
3.3.4 Discussion 
Radio-labelled serotonin appears to be metabolised to a greater extent than radio-labelled 
tryptophan. The major metabolite of both precursors is 5-hydroxyindoleacetic acid (HIAA). 
However, approximately six times more HIAA is produced as a result of serotonin 
metabolism compared to that of tryptophan. A possible reason for this is that a large amount 
of serotonin is taken up by the sympathetic nerve terminals and becomes subjected to 
monoamine oxidase degradation, whereas the tryptophan is preferentially taken up by the 
pinealocytes proper (Goridis and Neff, 1971). 
Considering that both precursors were of similar specific activity and the same radioactive 
concentration, significantly more serotonin was converted to N-acetylserotonin and melatonin 
than was tryptophan. This is probably due to the fact that serotonin only has to undergo a 
two-step conversion to melatonin whereas tryptophan enters the pathway at an earlier stage. 
In the nighttime study, tryptophan metabolism did not differ much from the daytime study 
except that melatonin production was higher in the nighttime study. Since N-acetylserotonin 
levels remained unchanged, it is possible that melatonin synthesis in the nighttime tryptophan 
study was due to conversion of methoxytryptamine to melatonin. 
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Compared with the daytime study, significantly more melatonin, N-acetylserotonin and 5-
hydroxyindoleacetic acid were produced during serotonin metabolism in the nighttime study. 
The rise in N-acetylserotonin and melatonin levels is expected, since N-acetyltransferase 
activity is known to be high during the dark phase in the intact rat pineal (Klein, 1979). 
However, the total monoamine oxidase products, including 5-hydroxyindoleacetic acid, were 
also elevated in the nighttime study of serotonin metabolism. At present, there is no evidence 
to indicate that nor-adrenaline stimulates pineal monoamine oxidase activity. These results 
suggest that nor-adrenaline activated monoamine oxidase activity, possibly in the sympathetic 
nerve terminals. 
TABLE 3.1 Metabolism of f 4Cj-tryptophan by organ culture of rat pineal glands 
(means + SEM, n = 6). 
-------- -- -----
DPM recovered as: % of total counts 
Total 
MEL NAS IDAA MIAA MAOP MEL MAOP 
Tryptophan (DS) 436 539 3010 371 4726 0.34 3.6 
+ 101 ±64 ± 159 ± 82 
Tryptophan (NS) 76P 525 3 148 267 4791 0.59 3.7 
± 159 ± 91 ± 273 ± 43 
(DS) Day Study; (NS) Night Study. 
MEL = melatonin, NAS = N-acetylserotonin, HIAA = 5-hydroxyindoleacetic acid, 
MIAA = 5-methoxyindoleacetic acid, MAOP = monoamine oxidase products. 
1 as compared with day study, p < 0.05, Student's t test. 
00 
o 
TABLE 3.2 Metabolism of t 4Cl-serotonin by organ culture of rat pineal glands 
(means ± SEM, n = 6). 
DPM recovered as: % of total counts 
Total 
MEL NAS mAA MIAA MAOP MEL MAOP 
Serotonin (DS) 1 364 1 146 18428 332 25962 1.1 
± 92 ± 107 ± 819 ± 68 
Serotonin (NS) 56051 34221 2958P 267 40 888 4.3 
± 348 ± 829 ± 1 103 ± 15 
(DS) Day Study; (NS) Night Study. 
MEL = melatonin, NAS = N-acetylserotonin, HIAA = 5-hydroxyindoleacetic acid, 
MIAA = 5-methoxyindoleacetic acid, MAOP = monoamine oxidase products. 
1 as compared with day study, P < 0.05, Student's t test. 
20.1 
31.6 
00 
...... 
82 
1000 ........................................................................................ , ......... -i 
"" 800 1-............................................................................. . ..................... . 
600 I-................................................................. t: 
.~ 400 
s:: 
o 
iil 
~ 
Q) 
::t: 200 
o 
Daytime Nighttime 
FIGURE 3.7 The [onnation o[ melatonin from t 4Cj-tryptophan by pineal glands in organ 
culture (means + SEM, n = 6). 
* as compared with the day study, p < 0.05, Student's t test. 
e 
::s 
.~ 
'C Q) 
e 
r-i 
83 
800 ......................................................................................................... . 
::t. 600 
o 
r-i 
" [ 
'C 
s:: 400 ............................................ + .............. ,r,lj 
.~ 
s:: 
o 
.j.J 
o ,., 
Q) 
rn 
r-i 
>0 200 
.j.J 
Q) 
U 
III 
J: 
o r·········~----------~··············~~~~~~·········~ 
Daytime Nighttime 
FIGURE 3.8 The formation of N-acetylserotonin from f 4Cj-tryptophan by pineal glands in 
organ culture (means + SEM. n = 6). 
...... 
e 
==' 
• ..j 
" OJ e 
84 
4000 .....•...•••....•.....••...•••....•.•.....•••..••.•....•...•••..••..••••..........•..•..•.•.•.•..•••••..••.•••• -1 
3000 I-·········r---+---'············,·· .. ~ 
2000 ····································I···············~/h 
Daytime Nighttime 
FIGURE 3.9 The formation of 5-hydroxyindoleacetic acid from t 4Cj-tryptophan by pineal 
glands in organ culture (means + SEM. n = 6). 
FIGURE 3.10 
...... 
3 
.,..j 
'0 
OJ 
e 
85 
500 ................................................... , ....... " ............................ , ...... " ........ ~ 
400 t······,······ .. ····························,·········· .................... . 
300 1-........ + ........ ·······,1··················1··,·······,··············· ... =::::r:::::: ..................... ~ 
200 1-.... " ... + .................................. +." ...... , ...... ~~ 
100 1-........ + ................................... + .............. ~ 
Daytime Nighttime 
The fonnation of 5-methoxyindoleacetic acid from 1!4Cj-tryptophan by 
pineal glands in organ culture (means + SEM, n = 6). 
FIGURE 3.11 
e 
::s 
.,..j 
1:1 Q) 
e 
86 
6000 
5000 
~ 4000 
:J.. 
o 
~ 
-~ 3000 
2000 
1000 
o 
Daytime Nighttime 
The formation of melatonin from t 4Cj-serotonin by pineal glands in 
organ culture (means + SEM, n = 6). 
* as compared with the day study, p < 0.05, Student's t test. 
FIGURE 3.12 
...... 
S 
::J 
.~ 
'0 
OJ 
S 
87 
5000 .......................................................................................................... -j 
~ 4000 
3000 ........................................................... ~q//. 
2000 /-............................................................... V'//~'///~ 
1000t ......... r==~~~.=.~+ ................ f 
o 
Daytime Nighttime 
The formation of N-acetylserotonin from /4Cj-serotonin by pineal 
glands in organ culture (means + SEM, n = 6). 
* as compared with the day study, p < 0.05, Student'S t test. 
FIGURE 3.13 
E 
;;1 
.,.,j 
" m 
.... 
::t. 
88 
40 000 ........................................................................................................ -1 
o ~ 30 000 ~ .......... , ............. ; .......................................... ;;;.n.;;;;;;:J:~>777" .......... ~ 
a 
" 
20 000 
10 000 1-······ .. ·1························· .. ·········· ............... .y: 
o 
Daytime Nighttime 
The formation of 5-hydroxyindoleacetic acid from t 4Cl-serotonin by 
pineal glands in organ culture (means + SEM, n = 6). 
* as compared with the day study, p < 0.05, Student's t test. 
FIGURE 3.14 
--3 
• ,..j 
"0 
~ 
.-I 
:.t. 
89 
400 t-................................................................................................... . 
~ 300 1-......... / .................... . 
-a 
"0 
"0 
.,..j 
U III 2 00 1-······ ... ·/······································1····· ...... . 
U 
.,..j 
.jJ 
Q) 
u III 
Q) 
.-I 
o 
'g 
.,..j 
>. 
>C 
o 
oJ:: 
.jJ 
~ 
100 ····································1·················-I' 
o 1-......... L----______ ~ ................ U~uu~~~ 
Daytime Nighttime 
The formation of 5-methoxyindoleacetic acid from f14el-serotonin by 
pineal glands in organ culture (means + SEM, n = 6). 
90 
3.4 Conclusion 
The results of the tryptophan profile show that nor-adrenaline stimulates in vitro pineal indole 
synthesis. It appears that N-acetyltransferase is stimulated to a greater extent than 
hydroxyindole-O-methyltransferase, resulting in an accumulation of N-acetylserotonin. 5-
Hydroxyindole levels were found to be high in comparison with 5-methoxyindole levels, 
suggesting possible ,a-adrenergic receptor involvement in monoamine oxidase regulation. 
The results show serotonin to be more readily metabolised to N-acetylserotonin and melatonin 
than tryptophan. This is probably due to the fact that serotonin only has to undergo a two-
stage conversion to melatonin, whereas tryptophan enters the pathway at an earlier stage. 
Once again, 5-hydroxyindoleacetic acid was found to be a major metabolite, pointing to 
monoamine oxidase involvement. 
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CHAPTER IV 
THE EFFECT OF S-ADENOSYL-L-:METmONINE 
ON PINEAL FUNCTION 
4.1 Introduction 
S-adenosylmethionine (SAM) is found in large quantities in pineal tissue (38.4 + 2.7 p.g/g 
tissue) (Baldessarini and Kopin, 1966). It is synthesised through the transfer of an adenosyl 
group from ATP to the sulphur atom of methionine. The methyl group of the methionine unit 
is activated, for donation, by the positive charge on the adjacent sulphur atom (Guchait and 
Grau, 1978). SAM is said to be the most important methyl donor in biological 
transmethylation reactions, including the methylation of biogenic amines such as melatonin 
(Quay, 1981). A closely related derivative, S-adenosylhomocysteine, which is formed either 
from homocysteine or by the loss of the active methyl group from SAM, inhibits the 
methylation of biogenic amines (Deguchi and Barchas, 1971). 
Recently, Zhong et al. (1990) showed that brain slices pre-incubated with SAM before being 
stimulated with nor-adrenaline or isoproterenol, potentiated cAMP production. This effect 
has not been demonstrated in the pineal gland in the literature investigated to date. 
The present study was carried out to determine SAM's effect on pineal function. For this 
investigation three assay methods were used, namely: organ culture assay, NAT assay and 
cAMP assay. 
4.2 Experiment 1: 
4.2.1 Introduction 
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The Effect of SAM on Pineal Indoleamine 
Metabolism. 
Research thus far has been restricted to examining the role of SAM in transmethylation 
reactions within the pineal gland. A recent report by Zhong et al. (1990), showed that SAM 
potentiated cAMP production in brain slices, stimulated via the .B-adrenergic receptor. 
The effect of SAM on the pineal gland was investigated using organ culture studies. This 
technique provides a holistic view of pineal activity through the measurement of pineal 
indoleamine levels. 
4.2.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1. The animals were sacrificed by neck fracture at llhOO for 
daytime studies and at 23hOO for nighttime studies. The collection of pineals for the 
nighttime studies was performed according to § 2.1. 
Chemicals and Reagents: 5-Hydroxy [side chain-2-14C]-tryptamine creatine sulphate 
(specific activity 57 mCi/mmol) was purchased from Amersham (England). 5-Adenosyl-l-
methionine was purchased from Boehringer Mannheim (West Germany) and I-isoproterenol 
from Sigma Chemical Co. (USA). All other chemicals and reagents were purchased from 
local commercial sources. 
Organ Culture: The pineal organ culture technique and the analysis of the radio-labelled 
indoles formed were performed as outlined in § 2.2.2. 
Experiment A: After sacrifice, the pineal glands were swiftly removed and placed 
individually into sterile glass tubes, each containing 52 ,Ill BGJb culture medium in the 
presence of (n = 5) and absence of (n = 5) 10 ,Ill of SAM at a final concentration of lO-sM. 
All tubes were incubated at 37°C in a humidified atmosphere of 95% ~ and 5% CO2 for 
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three hours, whereafter 8 J.LI of [14C]-serotonin was added to all tubes. The tubes were then 
re-incubated under the same conditions for 21 hours. 
In the case of isoproterenol-stimulated pineals, tubes were pre-incubated in the presence of 
(n = 5) and absence of (n = 5) 1(}5M SAM at 37°C in a humidified atmosphere of 95% O2 
and 5 % CO2, After three hours, isoproterenol at a fmal concentration of 10-5M and [14C]_ 
serotonin were added to all tubes, whereafter they were all re-incubated for 21 hours. 
The procedures mentioned above were followed for both daytime and nighttime studies. 
Experiment B: After sacrifice, the pineal glands were swiftly removed and placed 
individually into sterile glass tubes, each containing 52 J.LI BGJb culture medium in the 
presence of (n = 5) and absence of (n = 5) 10 J.Ll of SAM at a fmal concentration of 1(}5M. 
All tubes were incubated at 37°C in a humidified atmosphere of 95% O2 and 5% CO2 for 
three hours, whereafter 8 J.LI of [14C]-serotonin was added to all tubes. The tubes were then 
re-incubated under the same conditions for four hours. 
In the case of isoproterenol-stimulated pineals, tubes were pre-incubated in the presence of 
(n = 5) and absence of (n = 5) 1(}5M SAM at 37°C in a humidified atmosphere of 95% O2 
and 5 % CO2, After three hours, isoproterenol at a final concentration of 1O-5M and [14C]_ 
serotonin were added to all tubes, whereafter they were all re-incubated for four hours. 
The procedures mentioned above were performed for daytime studies only. 
After the incubation period (Experiment A, 24 hours and Experiment B, four hours) a 10 J.LI 
aliquot of culture medium was removed from each tube for analysis. The indoles in the 10 
J.Ll aliquots were isolated by TLC and quantified by liquid scintillometry as described in § 
2.2.2. 
All data were statistically compared using Student's t test and expressed as the mean of five 
separate incubations ± SEM. 
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4.2.3 Results 
Experiment A: SAM showed no significant effect on daytime indole metabolism in both 
unstimulated (Table 4.1) and stimulated (Table 4.2) pineal glands. Similarly, SAM showed 
no effect on nighttime indole metabolism in both unstimulated (Table 4.3) and stimulated 
(Table 4.4) pineal glands. 
Significant differences (p < 0.05) were however found between stimulated and unstimulated 
glands in both day and nighttime studies . 
Experiment B: After the four hour incubation the results followed a similar trend to that of 
Experiment A. No significant effect was shown by SAM on both unstimulated (Table 4.5) 
and stimulated (Table 4.6) pineal glands. 
Significant differences (p < 0.05) were however found between stimulated and unstimulated 
glands. 
4.2.4 Discussion 
SAM showed no effect on the metabolism of serotonin to N-acetylserotonin and melatonin 
by pineal glands in organ culture. This was observed in both day and nighttime experiments. 
The expected rise in the metabolism of indoles to N-acetylserotonin and melatonin in pineals 
stimulated with isoproterenol was observed in both day and nighttime studies. These fmdings 
support those of other workers (Axelrod et al., 1969; Deguchi, 1973) who demonstrated the 
role of .8-adrenergic receptor stimulation in indole metabolism. 
The absence of a significant effect in the 24 hour organ culture experiments promoted further 
investigations involving SAM. These investigations examined the role SAM played during 
the initial period of pineal indoleamine metabolism, i. e. the first four hours of metabolism. 
The early stage of metabolism is characterised by a sharp rise in melatonin and N-
acetyl serotonin levels with peaks being reached after approximately 16 hours (Banoo et al., 
1987). 
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SAM was once again found to exert no significant effect on the early stages of indoleamine 
metabolism in both stimulated and unstimulated pineal glands. The rise in pineal indoles was 
observed to be greater in those pineals stimulated with isoproterenol. 
TABLE 4.1 The effect of S-adenosyl-l-methionine pre-incubation on daytime unstimulated 
24 hour pineal indole metabolism (means + SEM; n = 5). 
---------
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 1 687 1 455 32095 35237 
+ 101 + 86 
SAM 1 676 1592 30444 33712 
+ 98 + 93 
SAM = S-adenosyl-l-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
\0 
0'\ 
TABLE 4.2 The effect of S-adenosyl-I-methionine pre-incubation on daytime isoproterenol-
stimulated 24 hour pineal indole metabolism (means + SEM; n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 3319 3865 28662 35846 
+ 391 +610 
SAM 3465 3876 37989 45330 
+ 472 + 560 
SAM = S-adenosyl-l-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
~ 
TABLE 4.3 The effect of S-adenosyl-l-methionine on nighttime unstimulated 24 hour pineal 
indole metabolism (means + SEM; n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 6210 5999 53304 65513 
± 1260 ± 840 
SAM 6 160 5554 56489 68203 
± 941 ± 902 
SAM = S-adenosyl-l-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
\0 
00 
TABLE 4.4 The effect of S-adenosyl-l-methionine pre-incubation on nighttime 
isoproterenol-stimulated 24 hour pineal indole metabolism 
(means ± SEM,' n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 7836 10 116 47871 65823 
± 920 ± 1480 
SAM 6004 9016 47 174 62 194 
± 1290 + 1 321 
SAM = S-adenosyl-l-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
\0 
\0 
TABLE 4.5 The effect ofS-adenosyl-l-methionine on daytime unstimulatedfour hour pineal 
indole metabolism (means + SEM; n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 395 700 13591 14686 
+ 26 ± 83 
SAM 368 543 17400 18311 
+ 53 ± 51 
SAM = S-adenosyl-l-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
...... 
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TABLE 4.6 The effect of S-adenosyl-l-methionine pre-incubation on daytime isoproterenol-
stimulated four hour pineal indole metabolism (means ± SEM; n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 688 997 24627 26312 
+ 34 + 93 
SAM 779 969 20275 22023 
+ 71 + 84 
SAM = S-adenosyl-I-methionine; MEL = melatonin; NAS = N-acetylserotonin; MAOP = 
monoamine oxidase products. 
..... 
o 
..... 
4.3 Experiment 2: 
4.3.1 Introduction 
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The Effect of In Vitro SAM Pre-incubation on Pineal 
NAT Activity. 
Serotonin N-acetyltransferase (NAT) is thought to be the rate limiting step in pineal indole 
metabolism (Klein et al., 1978). Interest in NAT regulation has grown due to its function 
as the enzyme responsible for the synthesis of N-acetylserotonin, the precursor of the pineal 
hormone melatonin. 
The reliance of NAT on cAMP for its synthesis and activation has been shown by many 
researchers. It is this fact and recent work by Zhong et al. (1990) which showed SAM to 
potentiate isoproterenol stimulation of cAMP, that led to this study. 
4.3.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1. The animals were sacrificed by neck fracture at 11hoo. 
Chemicals and Reagents: [1-14C]-Acetyl coenzyme A (specific activity 4.0 mCi/mmol) was 
purchased from Dupont Chemical Co. (USA). Tryptamine HCI and I-isoproterenol were 
purchased from Sigma Chemical Co. (USA) and unlabelled acetyl coenzyme A from Merck 
(West Germany). All other chemicals and reagents were purchased from local commercial 
sources. 
NAT Assay: After sacrifice, the pineal glands were swiftly removed and individually placed 
into sterile glass tubes each containing 60 ,ul of culture medium and SAM (n = 5) to a final 
concentration of lo-5M. Controls (n = 5) contained only culture medium. The tubes were 
incubated at 37°C in a humidified atmosphere of 95 % Oz and 5 % CO2 for three hours. After 
the incubation period, pineal glands were removed from their tubes, pooled, homogenised in 
500 ,ul of buffer and assayed for NAT activity according to § 2.3.2. 
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In isoproterenol-stimulated pineal glands, the pineals were initially pre-incubated in the 
presence of (n = 5) and absence of (n = 5) 10"5M SAM for three hours prior to 10"5M 
isoproterenol administration. Tubes were re-incubated for three hours, whereafter the pineals 
were removed from their tubes, pooled, homogenised in 500 Jotl of buffer and assayed for 
NAT activity according to § 2.3.2. 
All data were statistically compared using the Student's t test and expressed as NAT activity 
(pmol/ gland/hour). 
4.3.3 Results 
SAM exhibited no significant effect on both unstimulated (Figure 4.1) and stimulated (Figure 
4.2) pineal NAT activity. A significant difference (p < 0.05) was however found between 
stimulated and unstimulated groups. 
4.3.4 Discussion 
The pre-incubation of pineal glands with 10"5M SAM had little effect on pineal NAT activity 
in both stimulated and unstimulated glands. The expected rise in NAT activity in the 
presence of isoproterenol, a ,8-receptor agonist, was observed. This rise was significant (p 
< 0.05) when compared with unstimulated values. 
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4.4 Experiment 3: 
4.4.1 Introduction 
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The Effect of In Vitro SAM Pre-incubations on Pineal 
cAMP Levels. 
The existence of cAMP was first shown by Sutherland and RaIl (1958). Sutherland further 
showed that cAMP was synthesised from ATP via a membrane bound enzyme, adenylate 
cyclase, and was metabolised to AMP via the enzyme cAMP-phosphodiesterase (Sutherland 
et al., 1968). 
The importance of cAMP as a second messenger within the cell and its effect on NAT have 
been well documented. Stimulation of {1-adrenergic receptors results in an increase in cAMP 
levels in both brain and pineal tissue (Axelrod, 1974). SAM has been shown to increase 
brain receptor-mediated cAMP production in vitro (Zhong et al., 1990). The mechanism for 
this effect in brain tissue is not known but both phospholipid methylation (Hirata and 
Axelrod, 1980) and protein carboxy methylation (Buckland and Aksamit, 1988) by SAM have 
been proposed as important steps in the signal transduction. 
This study investigated the effect of in vitro SAM pre-incubations on pineal cAMP levels. 
4.4.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1. The animals were sacrificed by neck fracture at llhOO. 
Chemicals and Reagents: Tritiated cAMP (specific activity 30 Ci/mmol) was purchased 
from Amersham (England), standard cAMP from Boehringer-Mannheim (West Germany), 
theophylline and I-isoproterenol from Sigma Chemical Co. (USA) and activated charcoal form 
Merck (West Germany). All other chemicals and reagents were purchased from local 
commercial sources. 
Cyclic AMP Assay: The preparation of bovine cAMP-binding protein, pineal tissue and 
assay procedure were carried out as described in § 2.4.2. 
107 
Briefly, rats were sacrificed and the pineal glands rapidly removed. Pineals were placed into 
sterile glass tubes containing 300 J.'l of BGJb culture medium in the presence and absence of 
1O-5M SAM. The tubes were pre-incubated at 37°C for three hours in a humidified 
atmosphere of 95 % O2 and 5 % CO2• After the pre-incubation, Group 1 (n = 5) did not 
receive any further treatment and was used as the control. Group 2 (n = 5), which had been 
exposed to SAM (10-5M), did not receive any further treatment. Group 3 (n = 5) received 
isoproterenol at a fmal concentration of lo-5M and Group 4 (n = 5), which had been exposed 
to SAM (lO-sM), received isoproterenol at a fmal concentration of 1O-5M. After the above 
treatments, all pineals were re-incubated for five minutes at 37°C in a humidified atmosphere. 
Two further experiments were performed as described above with the exception that pineals 
were re-incubated for 15 and 30 minutes respectively. 
The incubations were terminated after five, 15 or 30 minutes respectively by homogenising 
each pineal individually in 100 J.'l of ice-cold phosphate buffer, pH 6.8. The assay was then 
carried out as outlined in § 2.4.2 and Table 2.3. 
All data were compared using Student's t test and expressed as cAMP concentration 
(pmol/ gland). 
4.4.3 Results 
Cyclic AMP levels showed little variation in daytime unstimulated pineal glands in the 
presence or absence of SAM. This held true for all incubation times (Figures 4.3, 4.4 and 
4.5). 
The opposite was found in daytime isoproterenol-stimulated pineal glands. At incubation 
times of five and 15 minutes (Figures 4.3 and 4.4 respectively) SAM pre-incubation was 
found to significantly (p < 0.05) reduce the stimulatory effect of isoproterenol on cAMP 
levels. This was, however, not the case after the 30 minute incubation (Figure 4.5) where 
cAMP levels were found to be similar in the presence or absence of SAM. No significant 
differences were observed between the SAM pre-incubated isoproterenol-stimulated groups. 
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4.4.4 Discussion 
The stimulation of /3-adrenergic receptors is essential for cAMP production (Axelrod, 1974). 
cAMP levels climb rapidly in the fIrst 10 to 15 minutes of receptor stimulation and return to 
base-line levels after approximately 30 minutes (Deguchi, 1973). The results of the control 
groups in this experiment are consistent with the above. On the other hand, the pre-
incubation of pineals with SAM was found to have a profound effect on isoproterenol-
stimulated cAMP levels. The characteristic climb of cAMP levels during the fIrst 15 minutes 
of stimulation was markedly reduced. This inhibitory effect was, however, not observed after 
30 minutes, which is typically marked by a return to base-line levels of cAMP. This 
phenomenon has been shown to be related to a decrease in adenylate cyclase activity 
(Deguchi, 1973). 
Interestingly, the inhibitory effect of SAM was found to be limited. Cyclic AMP levels were 
at all times greater than the control levels, suggesting that even in the presence of SAM /3-
receptor stimulation was still taking place. This, in turn, suggests that SAM could be 
exerting its inhibitory effect distal to the /3-adrenergic receptor i.e. either at the G protein, 
adenylate cyclase or on the enzyme cAMP-phosphodiesterase (by increasing its activity). 
These speculations need further investigation. 
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FIGURE 4.3 The effect of in vitro SAM pre-incubation onfive minute pineal cAMP levels, 
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4.5 Conclusion 
The rate-limiting enzyme in pineal indole metabolism, N-acetyltransferase (NAT), has been 
shown to be reliant on cAMP for its synthesis and activation (Klein et aI., 1978; Reiter, 
1991). Isoproterenol stimulation of pineal glands results in an increase in NAT activity, 
which in turn results in increased indole metabolism (Deguchi and Axelrod, 1972b; Mata et 
al., 1976). 
Pre-incubation of pineal glands with SAM, in 24 hour organ cultures, was found to have no 
significant effect on daytime isoproterenol-stimulated metabolism. Studies by Banoo et al. 
(1987) showed that pineal indole metabolism increased sharply in the first four hours of 
incubation. The experiment was repeated with the incubation time changed to four hours. 
The purpose of the shorter incubation time was to investigate the possibility that SAM might 
exert an effect during the early stages of pineal metabolism. The results showed that SAM 
exhibited no significant effect in the early stages of pineal indole metabolism. 
Further investigation into the effect of SAM on NAT found that the enzyme's activity 
remained unchanged in both the presence and absence of SAM. This was found in both 
stimulated and unstimulated pineal glands. These results thus support the fmdings of the 
organ culture assay. 
Having performed the organ culture and NAT assays first and finding that SAM exerted no 
significant effects, it was presumed that cAMP levels would remain unchanged. This was 
however not the case. 
Cyclic AMP levels were found to be significantly inhibited during the initial period of cAMP 
synthesis i. e. the first 15 minutes. These results are in direct contrast to those of Zhong et 
al. (1990) on brain tissue and to those of the organ culture and NAT assays performed earlier 
in this chapter. 
An explanation for the conflicting results in this study could be that: 
in the cAMP studies, the inhibitory effect produced by SAM was limited (i. e. the 
inhibition was not great enough to reduce cAMP levels to below control values), 
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suggesting that !'-receptor stimulation was still taking place in the presence of SAM. 
This could explain the attenuated !'-receptor response since the cAMP concentration 
could still be enough to allow normal indole metabolism as shown in the organ culture 
and NAT assays. 
This however does not explain the limited reduction in cAMP levels. It is possible that SAM 
affects cAMP levels by affecting regions distal to the !'-receptor such as adenylate cyclase, 
the regulatory G-proteins or cAMP-phosphodiesterase. In these situations, SAM may reduce 
adenylate cyclase activity or increase cAMP-phosphodiesterase activity and thereby alter 
pineal cAMP concentrations. 
These speculations, however, need further investigation. 
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CHAPTER V 
PURINE NUCLEOTIDE ACTION ON PINEAL ACTIVITY 
5.1 Introduction 
Exposure of rats to light during darkness (Klein and Weller, 1972) or the blocking of fJ-
adrenergic receptors in isoproterenol-stimulated rat pineal glands during darkness (Deguchi 
and Axelrod, 1972b) results in a rapid decline in N-acetyltransferase (NAT) activity. 
Maintenance of a high level of NAT activity requires continuous stimulation of the fJ-
adrenergic receptors on the pinealocytes. It appears unlikely that the precipitous fall in NAT 
activity is linked to cyclic AMP (cAMP) since pineal cAMP returns to baseline levels 30 
minutes after stimulation of the gland with fJ-adrenergic receptor agonists (Deguchi, 1973). 
The exact mechanism by which pineal NAT is inactivated remains unexplained. However, 
a number of agents have been shown to improve the stability of stimulated pineal NAT 
activity by protecting against its inactivation. For example, Binkley et al. (1976) 
demonstrated that 4 mM acetyl coenzyme A protected against heat-induced inactivation of 
pineal NAT activity at 37°C. This fmding was confirmed by Namboodiri et aZ. (1979) who 
also showed that high concentrations (20 mM) of nucleotide triphosphates and pyrophosphate 
protect against inactivation of NAT. However, it is unlikely that such concentrations could 
be reached in the pineal in vivo. 
S.2 Experiment 1: 
S.2.1 Introduction 
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The Effect of Adenosine S'-Monophosphate (S'_AMP) 
on Pineal NAT Activity 
This study investigates the possibility that the product of cAMP inactivation, viz. adenosine 
5' -monophosphate (5 '-AMP), may be involved in the regulation of pineal NAT. 
S.2.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described § 2.1. The animals were sacrificed by neck fracture at IlhOO for 
daytime experiments and 23hOO for nighttime experiments. 
The collection of pineal glands for the nighttime experiments was performed according to § 
2.1. 
Chemicals and Reagents: [1-14C]-Acetyl coenzyme A (specific activity 4.0 mCilmmol) was 
purchased from Dupont Chemical Co. (USA). [8-3H]-Adenosine 3' ,5 ' -cyclic phosphate 
(specific activity 30 Ci/mmol) was purchased from Amersham (England). 5 '-AMP and 
cAMP were purchased from Boehringer Mannheim (West Germany). I-Isoproterenol and 
theophylline were purchased from Sigma Chemical Co. (USA). All other chemicals and 
reagents were purchased from local commercial sources. 
Experiment A: The following experiment was performed to examine the effect of 5' -AMP 
on pineal NAT activity. Animals were sacrificed during the day (n = 10) and during the 
night (n = 10). After sacrifice, in each light phase, pineals were swiftly removed and 
individually homogenised in small glass homogenisers containing 100 ,al of phosphate buffer 
and assayed for NAT activity as described in § 2.3.2 in the absence of (n = 5) and presence 
of (n = 5) 1O-5M 5' -AMP. 
Experiment B: The following experiment was performed to examine the effect of 5' -AMP 
on isoproterenol-stimulated pineal NAT activity during the daytime. Animals were injected 
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intraperitoneally (ip) with isoproterenol (5 mg/kg) three hours before sacrifice. After 
sacrifice the pineals were individually homogenised in 100,ul of phosphate buffer and assayed 
for NAT activity as described in § 2.3.2, in the presence of (n = 5) and absence of (n = 5) 
lo-5M 5 ' -AMP. 
Experiment C: The following experiment was performed to examine the effect of a range 
of 5' -AMP concentrations on isoproterenol-stimulated pineal NAT activity. Animals were 
injected ip with isoproterenol (5 mg/kg) three hours before sacrifice. After sacrifice the 
pineals were pooled and homogenised in 500 ,Ill of phosphate buffer and assayed for NAT 
activity as described in § 2.3.2 in the presence of various concentrations of 5' -AMP ranging 
from lo-8M to 1O-3M. 
Experiment D: The following experiment was performed to examine the effect of an 
inhibitor of 5 ' -AMP formation, viz. theophylline, on pineal NAT and cAMP levels. Animals 
housed in darkness were injected ip with theophylline (10 mg/kg) at 21hOO with the aid of 
a dim, photo-safe red light. The animals were sacrificed at 23hOO, in the dark, whereafter 
the pineals were collected and assayed for NAT activity and cAMP as described in § 2.3.2 
and § 2.4.2 respectively. In order to perform the above experiment, a cAMP-
phosphodiesterase assay (§ 2.5.2) was performed to investigate the diurnal variation in 
phosphodiesterase activity. 
For the phosphodiesterase assay, the animals were sacrificed at 11hOO during the day and at 
23hOO during the night. 
Statistical differences between groups were determined using Student's t test. 
5.2.3 Results 
Experiment A: 5 '-AMP was found to have no effect on daytime NAT activity (Figure 5.1). 
However, in the nighttime study, 5' -AMP caused a significant (p < 0.05) enhancement of 
the dark-induced rise of this enzyme compared to controls (Figure 5.2). 
Experiment B: 5' -AMP (1O-5M) was found to potentiate the isoproterenol-induced rise in 
NAT activity (Figure 5.3). 
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Experiment C: The isoproterenol-induced rise in NAT activity observed in Experiment B 
(Figure 5.3) was also found to increase with increasing concentrations of 5' -AMP ranging 
between 10-8M and to-3M (Figure 5.4). 
Experiment D: Pineal cAMP-phosphodiesterase activity showed a significant (p < 0.05) 
increase during the dark phase (Figure 5.5). The administration of theophylline (10 mg/kg) 
two hours prior to sacrifice, in the early part of the dark phase, caused a significant (p < 
0.05) increase in pineal cAMP (Figure 5.6). This increase was accompanied by a significant 
(p < 0.05) decline in pineal NAT activity (Figure 5.7). 
5.2.4 Discussion 
It has been established that for pineal NAT activity to remain high, continual stimulation of 
the pineal ,8-adrenergic receptor is a prerequisite (Deguchi, 1973). Failure to stimulate the 
,8-adrenergic receptor by exposure of animals to light (Klein and Weller, 1972) or blockage 
of the ,8-adrenergic receptor with antagonists in stimulated pineals (Deguchi and Axelrod, 
1972b) results in a rapid and precipitous fall in NAT activity. This rapid inactivation of 
NAT does not appear to be linked to cAMP (Deguchi, 1973), since pineal cAMP levels 
return to baseline levels within 30 minutes of ,8-receptor stimulation. It is presently not 
known what factors are responsible for the rapid inactivation of NAT. Binkley et al. (1976) 
and Namboodiri et al. (1979) have shown that acetyl coenzyme A, nucleotide triphosphates 
and pyrophosphates protect NAT against inactivation at high concentrations (20 mM and 25 
mM respectively). 
The results of the present study show that 5' -AMP at a fmal concentration of lo-5M further 
enhances dark-induced as well as isoproterenol-induced NAT activity, and that a prerequisite 
for this effect is the stimulation of the pineal ,8-adrenergic receptor. In addition, 5 ' -AMP 
enhances isoproterenol-induced NAT activity in concentrations as low as 1Q-8M to 
concentrations as high as 1Q-3M. It appears therefore that 5' -AMP plays a regulatory role in 
the activation of pineal NAT. This is further supported by the fact that theophylline, a 
CAMP-phosphodiesterase inhibitor which reduces the conversion of cAMP to 5 I -AMP, caused 
an expected rise in pineal cAMP levels with a concomitant decline in pineal NAT activity 
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during the dark phase. It is thus possible for a lower availability of 5' -AMP to be responsible 
for the reduction in NAT activity. 
The inactivation of NAT through a rapid removal of pineal 5'-AMP by, for example, 
phosphorylation to ADP and A TP when animals are exposed to light at night is a possibility 
that remains to be investigated. 
119 
1 ................................................................................................................ -i 
J.I 
::s 0.8 o 
.r: 
...... 
'C 
t: 
lIS 
.-I 
~ 0.6 
.-I [ 
>. 0.4 
.j.l 
.r4 
> 
.r4 
.j.l 
o 
ICC 
~ 0.2 
........ ····································I················f 
o 
Control S'-AMP 
FIGURE 5.1 The effect of 105M 5 '-AMP on daytime unstimulated rat pineal NAT activity 
(means + SEM. n = 5). 
>. 
+I 
'" > 
'" +I U 
120 
10 ................................................................. ::::::;.:= ................ . 
* 8 .......................................................................... -t- ........................ -i 
6 1-............. , ......................................... . 
4 1-.......................................... , ........... ·············VhV~~ 
I( 2 1-.......................................................... , ...... -/' 
~ 
o 1-......... L----______ J ...... , ••••••••• ~~~~~u£ 
Control 5 ' -AMP 
FIGURE S.2 The effect of 105M 5 '-AMP on dark stimulated rat pineal NAT activity 
(means + SEM. n = 5). 
* as compared with the 5'-AMP free control, p < 0.05, Student's t test. 
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5.3 Experiment 2: 
5.3.1 Introduction 
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The Effect of Adenosine 5'-Triphosphate (ATP) on 
Pineal NAT Activity and Indoleamine Metabolism. 
Since the early 1970's a school of thought has emerged which proposes that ATP could act 
as a co-transmitter with nor-adrenaline in sympathetic nerve transmissions. The evidence for 
this to date is largely restricted to excitatory responses in smooth muscle. These responses 
are known to be elicited via the P2X purinoceptor sub-type (Kennedy, 1990). 
Adenosine, a related compound, has been shown to increase NAT activity in the pineal 
(Gharib et al., 1988). Nordio et al. (1989) were however unable to demonstrate this increase 
in NAT activity in similar experiments. The administration of ATP (20 mM) to pineal gland 
homogenates has been shown to protect the enzyme from inactivation over a 20 minute 
period. Furthermore, ATP at a concentration of 25 mM activates NAT in pineal 
homogenates (Namboodiri et al., 1979). 
The effect of ATP at more physiological concentrations on pineal indole metabolism and NAT 
activity remains unclear. This experiment investigates the effect of ATP on both NAT 
activity and pineal indoleamine metabolism. 
5.3.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1 and were sacrificed by neck fracture at 11hOO. 
Chemicals and Reagents: [1-14C]-Acetyl coenzyme A (specific activity 4.0 mCi/mmol) was 
purchased from Dupont Chemical Co. (USA). 5-Hydroxy [side chain-2-14C]-tryptamine 
creatine sulphate (specific activity 57 mCi/mmol) was purchased from Amersham (England). 
ATP was purchased from Boehringer Mannheim (West Germany) and I-isoproterenol was 
purchased from Sigma Chemical Co. (USA). All other chemicals and reagents were 
purchased from local commercial sources. 
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Experiment A: The following experiment was performed to examine the effect of ATP on 
pineal NAT activity. Animals (n = 10) were injected ip with isoproterenol (5 mg/kg) three 
hours before sacrifice. After sacrifice, the pineals were swiftly removed and individually 
homogenised in small glass homogenisers containing 100 ,ul of phosphate buffer and assayed 
for NAT activity as described in § 2.3.2 in the absence of (n = 5) and presence of (n = 5) 
lO-s M ATP. 
Experiment B: The following experiment was performed to examine the effect of A TP on 
pineal indoleamine metabolism. Animals (n = 10) were sacrificed at I1hOO whereafter the 
pineal glands were swiftly removed and placed individually into sterile glass culture tubes 
each containing BGJb culture medium, [14C]-serotonin, lO-sM isoproterenol (final 
concentration) in the absence of (n = 5) and presence of (n = 5) A TP at a final concentration 
of lO-sM. All tubes were incubated at 37°C for 24 hours in a humidified atmosphere of 95 % 
O2 and 5% CO2, 
After the incubation period, a 10 ,ul aliquot of the culture medium was removed from each 
tube for analysis. The indoles were isolated by TLC and quantified by liquid scinti1lometry 
as described in § 2.2.2. 
All data were statistically compared using Student's t test and expressed as the mean of five 
separate incubations + SEM. 
5.3.3 Results 
Experiment A: ATP caused a slight decrease in isoproterenol-stimulated NAT activity. 
However, this was not statistically significant (Figure 5.8). 
Experiment B: ATP was found to inhibit isoproterenol-stimulated pineal indole metabolism. 
Both melatonin and N-acetylserotonin synthesis were significantly (p < 0.05) reduced when 
compared with the ATP free control (Table 5.1). 
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5.3.4 Discussion 
The presence of ATP receptors that co-transmit with nor-adrenaline has been shown in tissues 
innervated by the sympathetic nervous system (Kennedy, 1990). The pineal gland is also 
heavily innervated by the sympathetic nervous system. This fact lends itself to the possibility 
that A TP may be involved in the regulation of pineal cellular processes. 
Organ culture experiments have shown themselves to be reliable methods for investigating 
pineal cellular activity. The results of this experiment showed that ATP (at a final 
concentration of lO-5M) in the presence of isoproterenol inhibited both N-acetylserotonin and 
melatonin synthesis. The reduction in N-acetylserotonin levels, the precursor to melatonin, 
points to the possibility that A TP may exert its inhibitory action either on the enzyme NAT, 
thereby reducing NAS levels, or at a point before the enzyme. 
The results of the NAT assay remain inconclusive in that no significant inhibition of NAT 
was observed in the presence of A TP. Further studies, particularly receptor studies, are 
necessary to investigate the presence of A TP receptors on the pineal cell surface. Present 
studies have, however, indicated an inhibitory interaction between A TP and the pineal gland. 
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FIGURE 5.8 The effect of ATP (lOsM) on daytime isoproterenol-stimulated NAT activity 
(means + SEM, n = 5). 
TABLE 5.1 The effect of ATP (l()5M) on daytime isoproterenol-stimulated pineal indole 
metabolism (means + SEM, n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 48841 30831 45374 53341 
+ 786 + 465 
ATP 2 139 525 26750 30378 
+ 563 + 91 
ATP = adenosine 5f-triphosphate; MEL = melatonin; NAS = N-acetylserotonin; MAOP 
= monoamine oxidase products. 
1 as compared with the ATP group, p < 0.05, Student's t test. 
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5.4 Experiment 3: 
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The Effect of Propranolol on Pineal Adenosine 
Nucleotide Levels in Three Hour Isoproterenol-
Stimulated Cultures. 
5.4.1 Introduction 
The synthesis of N-acetylserotonin, the precursor of melatonin, is regulated by the activity 
of NAT (Klein, 1979). NAT follows a diurnal rhythm with its activity being highest at night, 
in the dark (Deguchi and Axelrod, 1972a; Klein and Weller, 1972). The neurological 
components involved in the synthesis and activation of NAT also follows a diurnal rhythm. 
These components are thought to interact as follows: nor-adrenaline, released in greater 
quantities at night, binds to ,8-adrenergic receptors on the pineal cell surface (Deguchi and 
Axelrod, 1975). This binding results in increased levels of cellular cAMP through the 
activation of adenylate cyclase. Cyclic AMP activates protein synthesis which results in the 
synthesis of NAT. The activity of this NAT is dependent on the continued presence of nor-
adrenaline at the ,8-receptor (Axelrod, 1983; Ebadi, 1984). 
Purine nucleotides have repeatedly been shown to be important in the activity of the pineal. 
For example: 
cyclic AMP's essential role in the synthesis and activation of NAT, 
ATP's role as a cellular free energy source and its ability to protect NAT from 
inactivation (Namboodiri et al., 1979), and 
5'-AMP's ability to stimulate NAT activity (§ 5.2.3). 
It is therefore possible that these nucleotides act collectively in affecting pineal function. 
The purpose of this study was to investigate the effect of propranolol on nucleotide synthesis 
in three hour isoproterenol-stimulated organ cultures. Propranolol was used in this study to 
mimic the effect of light by competing with isoproterenol for the ,8-receptor. 
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5.4.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained and sacrificed as described in § 2.1. 
Chemicals and Reagents: [2-3H]-Adenosine (specific activity 26 Ci/mmol) was purchased 
from Amersham (England). Unlabelled adenosine 5' -triphosphate, adenosine 5'-diphosphate, 
adenosine 5'-monophosphate and cyclic adenosine 3' ,5 '-monophosphate were purchased from 
Boehringer Mannheim (West Germany). I-Isoproterenol and propranolol were purchased 
from Sigma Chemical Co. (USA). Plastic TLC plates (50 mm x 200 mm) coated with 
polyethyleneimine cellulose (polygram-, Cel 300 PEI/UV254) 0.1 mm were purchased from 
Macherey-Nagel (West Germany). BGJb culture medium (Fitton-Jackson modification) was 
purchased from Gibco (Europe). All other chemicals and reagents were purchased from local 
commercial sources. 
Assay: The assay was carried out as described in § 2.6.2. Briefly, rats were sacrificed and 
the pineal glands rapidly removed and scored with a sterile scalpel. The pineals were placed 
in groups of five into sterile glass culture tubes containing [3H]-adenosine and BGJb culture 
medium to a final volume of 3oo,ul. The tubes were pre-incubated at 37°C in a humidified 
atmosphere of 95% O2 and 5% CO2 for three hours in the presence or absence of 10"5M 
isoproterenol. After the pre-incubation, Group 1, which had not been exposed to 
isoproterenol, did not receive any further treatment and was used as the control. Group 2, 
which had been exposed to isoproterenol (l0-5M) for three hours, did not receive any further 
treatment. Group 3, which had been exposed to isoproterenol (l0"5M), received propranolol 
at a final concentration of 1Q-4M. The tubes were then re-incubated for one hour at 37°C in 
a humidified atmosphere of 95 % O2 and 5 % CO2, 
After the incubations, the pineals were removed and individually homogenised in small glass 
homogenisers containing 100 ,ul distilled water. The homogenates were centrifuged at 6000 
rpm for one minute, whereafter 10 ,ul of the supernatant was removed from each tube for 
TLC analysis. After separation, the spots were scraped into plastic scintillation vials 
containing 3 ml scintillation cocktail (Ready-Solv HP, Beckman) and shaken for five minutes. 
After shaking, the radioactivity was quantified by liquid scintillometry. 
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5.4.3 Results 
Results are presented in Table 5.2. 
A TP levels were found to be similar between the unstimulated control and the isoproterenol-
stimulated groups. A significant difference (p < 0.001) was however found in the 
isoproterenol + propranolol group when compared with both the control and isoproterenol 
groups (Figure 5.9). 
ADP levels varied significantly (p < 0.001) between groups. Recorded levels were highest 
in the isoproterenol group and lowest in the isoproterenol + propranolol group (Figure 5.10). 
5'-AMP and cAMP levels (Figures 5.11 and 5.12 respectively) followed inverse relationships 
within each experimental group, with the isoproterenol group showing both the highest 5'-
AMP level and the lowest cAMP level. 
5.4.4 Discussion 
The nocturnal release of nor-adrenaline precipitates a cascade of events within the pineal, one 
of which is the activation of adenylate cyclase. This activation results in increased 
intracellular cAMP levels (Deguchi, 1973). Isoproterenol, a fj-receptor agonist, produces the 
same effect as nor-adrenaline during the day and also stimulates cAMP-phosphodiesterase 
activity (Brown et ai., 1989b). 
The results of the present study show that nucleotide levels remain constant in unstimulated 
daytime pineals. The isoproterenol-stimulated group produced high 5'-AMP and ADP levels 
whereas the isoproterenol + propranolol group produced high A TP and cAMP levels and low 
5' -AMP and ADP levels. 
The high levels of 5'-AMP in the isoproterenol group were predictable, considering that 
isoproterenol stimulates both cAMP production and its metabolism to 5' -AMP through 
adenylate cyclase and cAMP-phosphodiesterase, respectively. The high levels of ADP found 
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within the isoproterenol group could result from increased re-phosphorylation due to high 
levels of the substrate, 5' -AMP. 
The stimulatory effect of isoproterenol appears to be reduced in the pineals incubated with 
propranolol. The high levels of ATP and lower levels of 5'-AMP found within the 
isoproterenol + propranolol group compared with the isoproterenol group could be ascribed 
to a reduction in both adenylate cyclase and cAMP-phosphodiesterase activity. This could 
be due to the presence of the fj-receptor antagonist and to a lower requirement for A TP 
during unstimulated periods. Low ADP levels could result from a lower rate of re-
phosphorylation owing to low substrate levels. 
The differences observed between the different experimental groups lends itself to speculation 
on its significance in relation to pineal function. 
During unstimulated periods (daytime) the requirement of the pineal for nucleotides is limited, 
resulting in an equilibrium or steady state between the nucleotides. Alternatively, during 
stimulated periods (nighttime) cAMP and 5 '-AMP levels are raised due to a higher fj-receptor 
occupancy. This increase disrupts the equilibrium and tilts it to the left, thereby activating 
cellular processes. The shifting of the balance to the right i. e. increasing A TP and ADP 
levels while reducing cAMP and 5' -AMP levels, could produce an inhibitory effect, acting 
as a switch to "turn off' the activated cellular processes. It is therefore possible that a "see-
saw" effect is present within the pineal which produces stimulatory or inhibitory responses 
depending on which side the nucleotide balance is tilted. 
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TABLE 5.2 The effect of propranolol on adenosine nucleotide levels in three hour 
isoproterenol-stimulated pineal cultures (means ± SEM, n = 5). 
Nucleotide Concentrations (fmol/gland) 
ATP ADP 5' -AMP cAMP 
Control 54.6 65.62 65.0 84.14 
± 1.9 ± 1.4 ± 1.2 ± 2.3 
Isoproterenol 52.2 107.83 222.23 48.3 
± 1.8 ± 3.0 ± 7.8 ± 1.9 
Isoproterenol + 75.81 47.5 78.7 83.84 
Propranolol ± 1.7 ± 0.8 ± 1.8 ± 1.8 
ATP = adenosine 5'-triphosphate; ADP = adenosine 5'-diphosphate; 5'-AMP = adenosine 
5'-monophosphate; cAMP =adenosine 3~5'-cyclic phosphate. 
1 as compared with both the control and isoproterenol groups, p < 0.001 
2 as compared with the isoproterenol + propranolol group, p < 0.001 
3 as compared with both the control and the isoproterenol + propranolol groups, p < 0.001 
4 as compared with the isoproterenol group, p < 0.001 
All groups were statistically compared using, one-way ANOVA followed by the Bonferroni 
multiple range test. 
t: 
o 
• ..j 
+J 
f\l 
\..j 
+J 
t: 
OJ 
o 
t: 
o 
U 
OJ 
'0 
• ..j 
+J 
o 
OJ 
r-I 
o 
::l 
Z 
136 
80 .............................................................................................................................................. . 
60 .................................................................................................. [><XX>C 
40 ·······························I,,············~ 
20 
o 
control Iso Iso + Prop 
FIGURE 5.9 The effect o!isoproterenol (Iso) and isoproterenol + propranolol (Iso + Prop) 
on daytime adenosine 5'-triphosphate (ATP) concentrations in three hour 
pineal cultures (means ± SEM, n = 5). 
* as compared with both the isoproterenol free control and isoproterenol 
groups, p < 0.001, one-way ANOVA followed by the Bonferroni 
multiple range test. 
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0.001 
as compared with both the isoproterenol free control and 
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ANDV A followed by the Bonferroni multiple range test. 
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The effect o/isoproterenol (Iso) and isoproterenol + propranolol (Iso 
+ Prop) on daytime adenosine 5'-monophosphate (5 '-AMP) 
concentrations in three hour pineal cultures (means + SEM. n = 5). 
* as compared with both the isoproterenol free control and 
isoproterenol + propranolol groups, p < 0.001, one-way 
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Control Iso Iso + Prop 
The effect o!isoproterenol (Iso) and isoproterenol + propranolol (Iso 
+ Prop) on daytime cyclic adenosine 3',5'-monophosphate (cAMP) 
concentrations in three hour pineal cultures (means + SEM, n = 5). 
* as compared with both the isoproterenol free control and the 
isoproterenol + propranolol groups, p < 0.001, one-way 
ANOV A followed by the Bonferroni multiple range test. 
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5.5 Conclusion 
The investigation into the effect of 5' -AMP on NAT activity revealed that 5' -AMP stimulated 
NAT activity in both dark- and isoproterenol-stimulated pineals. 5' -AMP's stimulatory effect 
appeared to be inhibited in the presence of a cAMP-phosphodiesterase inhibitor, reaffirming 
the idea that 5' -AMP, rather than cAMP, is important for sustained NAT activity in the 
presence of a .a-receptor agonist. However, A TP was found to inhibit indoleamine 
metabolism and also appeared to reduce NAT activity in the presence of {j-receptor agonist. 
It therefore appears that 5 ' -AMP and ATP act antagonistically in the regulation of NAT 
activity. 
The above results led to further investigations into the collective effect of adenosine 
nucleotides on pineal function. These investigations demonstrated a trend in pineal nucleotide 
levels at different metabolic states. At rest (daytime) the pineal appeared to flx its nucleotide 
levels according to its requirements for them. Stimulation resulted in a demand for cAMP 
and 5' -AMP, thereby depleting A TP levels. The sudden blockade of .a-receptors by 
propranolol in stimulated pineals, resulted in the depletion of high 5 ' -AMP levels and an 
increase in ATP, possibly via a re-phosphorylation of 5 '-AMP through ADP to ATP. It is 
therefore possible that a "switch" is produced by the levels of nucleotides within the pineal 
relative to one another. Furthermore, this "switch" may be turned "on/off" via external 
stimuli e.g. light acting through the {j-adrenergic receptor. 
If the above holds true, the sudden inactivation of NAT at night after exposure of animals to 
light may be explained by a shift in nucleotide levels towards A TP and a depletion of cAMP 
and 5 ' -AMP. 
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CHAPTER VI 
THE EFFECT OF CALCIUM MANIPULATIONS ON THE 
RAT PINEAL GLAND 
6.1 Introduction 
Calcium plays an important role in the regulation of many cellular processes, such as the 
regulation of enzymes (Cohen, 1982) and the secretion of hormones (Katz, 1969; Baker and 
Knight, 1981). Within the pineal gland, calcium fluxes affect the secretion of melatonin and 
pinea10cyte enzyme activity (Brown et al., 1989b). 
Calcium cellular concentrations vary between different cell types, with resting pinealocyte 
calcium concentrations estimated at approximately 0.05 to 0.5 j.LM (Reuter, 1983). It is 
important to note that these concentrations represent the free cellular calcium i. e. that found 
in the cytoplasm. Within the cytoplasm, calcium has been shown to aggregate into 
precipitates (Pizarro et aI., 1989). Higher calcium concentrations have been detected in 
pinealocyte mitochondria and nuclei of animals sacrificed at night. This could possibly 
indicate a change in the functional state of the cell during nocturnal calcium fluxes (Pizarro 
et al., 1989). 
The calcium signal is an important component of the nor-adrenergic regulation of the 
synthetic and secretory activities of the pineal gland (Sugden et al., 1987). Adrenergic 
stimulation of the pineal results in increased cellular levels of cAMP (Klein et al., 1989). 
Cyclic AMP regulates the synthesis of serotonin N-acetyltransferase, the rate-limiting enzyme 
in the synthesis of melatonin (Axelrod, 1974). In vitro studies by Sugden et aZ. (1985) 
demonstrated the action of calcium at the receptor level within this mechanism, where its 
presence is required by both a- and (1-receptors in cAMP synthesis. The a-receptor is reliant 
on calcium for its potentiation of (1-receptor cAMP synthesis, through protein kinase C 
(Sugden et aZ., 1985). 
6.2 Experiment 1: 
6.2.1 Introduction 
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The Effect of Calcium on NAT Activity in Rat Pineal 
Gland Homogenates. 
The synthesis of the pineal hormone, melatonin, is regulated primarily by a classic {3-
adrenergic receptor system where calcium plays an important role (Brown et al., 1989b). 
During the synthesis of melatonin in the pineal gland, the enzyme N-acetyltransferase 
catalyses the conversion of serotonin to N-acetylserotonin, the precursor of melatonin 
(Weissbach et al., 1960; Axelrod and Weissbach, 1961). The activity of NAT is presently 
used as an indicator of pineal activity (Rodriguez-Cabello et al., 1990b). The exposure of 
rats to light during the dark phase of the diurnal light cycle induces a rapid decline in pineal 
NAT activity (Klein and Weller, 1972). Such a decline has also been observed during 
homogenisation of stimulated pineal glands (Binkley et al., 1976). 
Previous studies have shown that calcium channel blockers reduce the nocturnal rise in pineal 
NAT activity (Zawilska and Nowak, 1991). It has yet to be established whether calcium is 
directly involved in the synthesis of de novo NAT protein, or whether it is an activator of 
NAT in the pineal. However, it has been shown that chelation of extracellular calcium 
results in a reduction of NAT activity due to reduced {3-adrenergic receptor sensitivity and 
reduced NAT protein synthesis (Zatz and Romero, 1978). A recent study using the chelating 
agent ethyleneglycol-bis-N,N,N,N,-tetraacetic acid (EGTA) in pineal homogenates, from 
isoproterenol-treated rats, has shown that EGTA reduces the rate of deactivation of NAT 
(Rodriguez-Cabello et al., 1990a). 
The purpose of this study was to investigate the effect of calcium as well as its chelation on 
NAT activity in pineal gland homogenates. 
6.2.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1. The animals were sacrificed by neck fracture at 11hOO. 
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Chemicals and Reagents: [l-14C]-Acetyl coenzyme A (specific activity 4.0 mCi/mmol) was 
purchased from Dupont Chemical Co. (USA). EGTA, I-isoproterenol and tryptamine HCl 
were purchased from Sigma Chemical Co. (USA). Cold acetyl coenzyme A was purchased 
from Boehringer Mannheim (West Germany). Calcium chloride was purchased from BDH 
Chemicals Ltd (England). All other chemicals and reagents were purchased from local 
commercial sources. 
Experiment A: The following experiment was performed to investigate the effect of a range 
of calcium concentrations on daytime isoproterenol-stimulated NAT activity. Briefly, animals 
(n = 5) were injected ip with isoproterenol (5 mg/kg) three hours prior to sacrifice. The 
pineals were swiftly removed, pooled and homogenised in 500 J.d phosphate buffer pH 6.8. 
The homogenate was assayed for NAT activity (as described in § 2.3) in the presence of 
various final concentrations of calcium chloride ranging from lo-3M to lo-8M. 
Experiment B: The following experiment was performed to investigate the effect of calcium 
on the loss of NAT activity. Briefly, animals (n = 10) were injected ip with isoproterenol 
(5 mg/kg) three hours prior to sacrifice. Pineal glands were removed and pooled into two 
groups and homogenised. Aliquots from the two homogenates were incubated on ice for 0, 
5, 10, 15, 20, 25 and 30 minutes without the addition of NAT substrate, in the presence of 
(n = 5) and absence of (n = 5) calcium chloride at a final concentration of lo-3M. After the 
pre-incubation period, NAT substrate was added and the NAT activity assayed as described 
in § 2.3. 
Experiment C: The following experiment was performed to investigate the effect of EGTA 
on the loss of NAT activity in pineal gland homogenates. Briefly, animals (n = 10) were 
injected ip with isoproterenol (5 mg/kg) three hours prior to sacrifice. The pineal glands 
were removed, pooled and homogenised in phosphate buffer pH 6.8. Tubes were incubated 
on ice in the presence of EGTA (either 1 mM or 10 mM, final concentration) or in the 
absence of EGTA for varying time periods (0, 5, 10, 15, 20, 25 and 30 minutes) in the 
absence of NAT substrate. After the designated time, NAT substrate was added and NAT 
activity assayed as described in § 2.3. 
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6.2.3 Results 
Experiment A: NAT activity increased from 1.21 ± 0.05 pmollgland/hour at a 1O-3M 
calcium concentration to 1.25 ± 0.08 pmollgland/hour at a 1O-8M calcium concentration 
(Figure 6.1). It appears that calcium at a concentration as low as lQ-8M, reduces NAT 
activity as compared with the calcium free control (1.4 + 0.05 pmol/gland/hour). 
Experiment B: The loss of NAT activity in the presence of lQ-3M calcium is shown in 
Figure 6.2. In the absence of calcium, NAT activity dropped from 1.89 + 0.02 to 1.03 + 
0.03 pmol/gland/hour over a period of 30 minutes. However, in the presence of calcium, 
NAT activity fell from 1.15 ± 0.04 to 0.7 + 0.02 pmol/gland/hour over the same period. 
Experiment C: Both 1 mM and 10 mM EGTA prevented the loss of NAT activity over a 
30 minute period when compared with the EGTA free control. Of the two concentrations, 
1 mM EGTA gave the highest overall value (Figure 6.3). Comparing initial NAT activities 
at zero time, the 10 mM EGTA gave the most NAT activity protection (2.83 + 0.26 
pmol/gland/hour) (Figure 6.4). 
6.2.4 Discussion 
Chelation of extracellular calcium has been shown to reduce NAT activity by reducing both 
protein synthesis and t1-adrenergic receptor sensitivity (Zatz and Romero, 1978). 
On the other hand, chelation of calcium in pineal homogenates resulted in an increase in the 
initial NAT activity and a reduction in the rate of deactivation of the enzyme (Rodriguez-
Cabello et ai., 1990a). The results of this investigation support the view that EGTA, a 
chelating agent, protects NAT from inactivation and further suggests that EGT A enhances 
NAT activity. One millimolar EGT A appeared to provide the greatest overall protection over 
a 30 minute period, while 10 mM EGTA provided the highest initial NAT activity (at zero 
time). The addition of calcium was found to significantly reduce NAT activity in a 
concentration-dependent manner. 
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The mechanism for the activation or inactivation of NAT in the presence of both EOT A and 
calcium remains unclear. However, it is possible that calcium may affect a NAT inhibitory 
compound (Chan and Ebadi, 1981; Khoory and Schloot, 1986; Lerchl et al., 1991) which 
may be responsible for the regulation of NAT. 
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6.3 Experiment 2: 
6.3.1 Introduction 
150 
The Effect of the Calcium Ionophore 1\23187 on Pineal 
Indoleamine Metabolism. 
The previous experiment demonstrated the inhibitory effect of calcium on pineal NAT activity 
in pineal gland homogenates. The opposite has been observed in intact pineal glands, where 
the chelation of extracellular calcium resulted in a decrease in NAT activity through an 
indirect effect on the rate of protein synthesis and is-receptor expression (Wilkinson, 1976; 
Zatz and Romero, 1978). However, long-term exposure of intact pineal glands to elevated 
calcium levels leads to a reduction in NAT activity (Wilkinson, 1978) through the activation 
of a NAT inhibitory substance (Chan and Ebadi, 1981; Khoory and Schloot, 1986; Lerch! 
et ai., 1991). 
This study investigates the effect of the calcium ionophore A23187 on pineal indoleamine 
metabolism as a measure of pineal enzyme activity. The advantage of using A23187 is that 
it is selective for divalent ions (pressman, 1976). It is therefore capable of stimulating 
calcium-dependent reactions, without disturbing pre-existing balances of sodium and 
potassium, by rapidly introducing calcium into cells under mild experimental conditions 
(Brown, 1992). 
6.3.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1 and were sacrificed by neck fracture at 11hOO. 
Chemicals and Reagents: 5-Hydroxy [side chain-2-14C]-tryptamine creatine sulphate 
(specific activity 57 mCi/mmol) was purchased from Amersham (England). I-Isoproterenol 
was purchased from Sigma Chemical Co. (USA). A23187 was purchased from Boehringer 
Mannheim (West Germany). Dimethyl sulphoxide (DMSO) of analytical grade and all other 
chemicals and reagents were purchased from local commercial sources. 
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Assay Procedure: Animals (n = 10) were sacrificed at 11hOO, whereafter the pineals were 
swiftly removed and placed individually into sterile glass culture tubes each containing BGJb 
culture medium, p4C]-serotonin and 1O-5M isoproterenol (final concentration) in the presence 
of (n = 5) and absence of (n = 5) A23187 at a fmal concentration of 10 #-,M. All tubes were 
incubated at 37°C for 24 hours in a humidified atmosphere of 95% ~ and 5% CO2, 
After the incubation period, 10 #-,1 aliquots of the culture medium were removed from each 
tube for analysis. The indoles in the aliquots were isolated by TLC and quantified by liquid 
scintillometry as described in § 2.2.2. 
A stock solution of A23187 (0.1 M) was made up in DMSO and serially diluted in culture 
medium to the desired experimental concentration. DMSO (1 %) solvent alone showed no 
effect on indoleamine metabolism. 
6.3.3 Results 
The calcium ionophore A23187 appeared to inhibit daytime isoproterenol-stimulated 
indoleamine metabolism (Table 6.1). Furthermore, N-acetylserotonin and melatonin levels 
were significantly reduced in the presence of A23187 (Figures 6.S and 6.6). 
6.3.4 Discussion 
The introduction of the calcium ionophore A23187 into the organ culture assay method 
promoted the movement of large quantities of calcium into the pineal. The results of this 
investigation show that A23187 reduces indoleamine metabolism in daytime isoproterenol-
stimulated pineals. These results further support the earlier study (§ 6.2) which demonstrated 
that high calcium concentrations retarded NAT activity, while its chelation promoted NAT 
activity. 
The above results are in contrast to reports by Vanecek et al. (1986) and Brown (1992) which 
demonstrated A23187 to potentiate isoproterenol-stimulated cAMP production and increase 
NAT activity (Brown, 1992). 
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It is presently unclear whether calcium's action on NAT is as a result of a calcium-dependent 
inhibitory compound or the direct interaction between NAT and calcium ions. 
TABLE 6.1 The effect of A23187 on daytime isoproterenol-stimulated pineal indoleamine 
metabolism (means + SEM,· n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 44861 396P 36094 44541 
+ 361 ± 163 
A23l87 3468 3089 29693 36250 
+ 236 ± 323 
MEL = melatonin; NAS = N-acetylserotonin; MAOP = monoamine oxidase products. 
1 as compared with the A23l87 group, p < 0.05, Student's t test. 
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FIGURE 6.5 The effect of A23187 on daytime isoproterenol-stimulated N-acetylserotonin 
levels (means ± SEM, n = 5). 
* as compared with the A23187 group, p < 0.05, Student's t test. 
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FIGURE 6.6 The effect of A23187 on daytime isoproterenol-stimulated melatonin levels 
(means + SEM, n = 5). 
* as compared with the A23187 group, p < 0.05, Student's t test. 
6.4 Experiment 3: 
6.4.1 Introduction 
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The Effect of Calmidazolium (R24S71) on Pineal 
Activity. 
In 1970, Rasmussen afforded calcium "second messenger" status because of its diverse 
cellular functions. Calcium's intracellular mechanisms have only recently become 
understood. One such mechanism operates through a calcium binding protein which in turn 
activates other intracellular enzymes. It has been suggested that calmodulin, the most 
abundant of these calcium binding proteins, serves an analogous role towards calcium as does 
protein kinase towards cAMP (Klee and Haiech, 1980; Brown, 1992). 
Calmodulin has been found in high concentrations in several mammalian tissues (Hidaka et 
al., 1979) including the pineal gland (Zhou et al., 1985). In these tissues, calmodulin-
stimulated cAMP-phosphodiesterases have also been identified (Beavo et al., 1982; Klee and 
Vanalan, 1982). The mechanism of the interaction between calmodulin and cAMP-
phosphodiesterase has been discussed in § 1.10.2.3. 
In the pineal, cAMP-phosphodiesterase is characterised by its two forms, namely a high-Km 
form and a low-Km form. It is believed that the high-Km form is cytosolic while the low-Km 
form is membrane-bound (Wells and Hardman, 1977). The membrane-bound enzyme is 
thought to maintain cAMP levels during steady state conditions, whereas the cytosolic enzyme 
becomes critical during an upsurge in cAMP levels, for example during stimulated periods. 
The importance of calmodulin in translating the "calcium signal" into the pineal cell through 
its action on adenylate cyclase and cAMP-phosphodiesterase is of paramount importance to 
pineal function. This experiment investigated the effect of calmidazolium (R24571), a 
calmodulin inhibitor, on pineal indoleamine metabolism, cAMP levels and cAMP-
phosphodiesterase activity. 
157 
6.4.2 Materials and Method 
Male Wistar rats weighing between 200 and 250 g were used in this study. The animals were 
maintained as described in § 2.1 and were sacrificed by neck fracture at 11hOO. 
Chemicals and Reagents: 5-Hydroxy [side chain-2-14C]-tryptamine creatine sulphate 
(specific activity 57 mCi/mmol) and [8-3H]-adenosine 3' ,5 '-cyclic phosphate (specific activity 
30 Ci/mmol) were purchased from Amersham (England). I-Isoproterenol was purchased from 
Sigma Chemical Co. (USA). Calmidazolium (R24571), cold cAMP and 5' -AMP were 
purchased from Boehringer Mannheim (West Germany). Dimethyl sulphoxide (DMSO) of 
analytical grade and other chemicals and reagents were purchased from local commercial 
sources. 
Experiment A: The following experiment was performed to investigate the effect of R24571 
on pineal indoleamine metabolism. Animals (n = 10) were sacrificed, the pineals swiftly 
removed and individually placed into sterile glass culture tubes each containing BGJb culture 
medium, [14C]-serotonin and isoproterenol 1O-5M (final concentration) in the presence of (n 
= 5) and absence of (n = 5) R24571 10 JLM (final concentration). All tubes were incubated 
at 37°C for 24 hours in a humidified atmosphere of 95% ~ and 5% CO2• 
After the incubation period, 10 1'1 aliquots of the culture medium were removed from each 
tube for analysis. The indoles present were isolated by TLC and quantified by liquid 
scintillometry as described in § 2.2.2. 
A stock solution of R24571 (0.1 M) was made up in DMSO and serially diluted in culture 
medium to the desired experimental concentration. DMSO (1 %) solvent alone showed no 
effect on indo1eamine metabolism. 
Experiment B: The following experiment was performed to investigate the effect of R24571 
on pineal cAMP levels. Animals (n = 10) were sacrificed, the pineal glands swiftly removed 
and individually placed into sterile glass culture tubes each containing BGJb culture medium 
in the presence of (n = 5) and absence of (n = 5) R24571 (10 I'M). After a 30 minute pre-
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incubation at 37°C, isoproterenol (10-sM) was added to all tubes. Thereafter, the tubes were 
re-incubated at 37°C for three hours in a humidified atmosphere of 95% ~ and 5% CO2• 
After incubation, the pineals were removed and assayed for cAMP as described in § 2.4, with 
the exception that cAMP-phosphodiesterase inhibitors were omitted from buffer solutions. 
Experiment C: The following experiment was performed to investigate the effect of R24571 
on pineal cAMP-phosphodiesterase activity. Animals (n = 10) were sacrificed, the pineal 
glands swiftly removed and individually placed into sterile glass culture tubes each containing 
BGJb culture medium in the presence of (n = 5) and absence of (n = 5) R24571 (10 jJ.M). 
After a 30 minute pre-incubation at 37°C, isoproterenol (1o-sM) was added to all tubes. 
Thereafter, the tubes were re-incubated at 37°C for three hours in a humidified atmosphere 
of 95% O2 and 5% CO2• 
After incubation, the pineals were removed and assayed for cAMP-phosphodiesterase activity 
as described in § 2.5. 
6.4.3 Results 
Experiment A: The results in Table 6.2 show that R24571 inhibits pineal indoleamine 
metabolism. The metabolism of serotonin to N-acetylserotonin and melatonin was 
significantly reduced in the presence of R24571 (Figures 6.7 and 6.8). 
Experiment B: Pineal cAMP levels increased significantly in the presence of R24571 (11.0 
+ 0.43 pmol/gland) when compared with the R24571 free controls (8.2 + 0.5 pmol/gland) 
(Figure 6.9). It is important to note that these results were obtained in the absence of cAMP-
phosphodiesterase inhibitors. 
Experiment C: Pineal cAMP-phosphodiesterase activity was significantly reduced in the 
presence of R24571 (Figure 6.10). The levels were found to decrease from 1.02 + 0.03 
pmol/gland/hour in the control to 0.34 ± 0.01 pmol/gland/hour in the test sample containing 
R24571. 
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6.4.4 Discussion 
The inhibition of pineal indoleamine metabolism, particularly the reduction in the conversion 
of serotonin to N-acetylserotonin, suggests that calmidazolium (R24571) affects N-
acetyltransferase activity. The results of the cAMP studies show that R24571 enhances pineal 
cAMP levels with a concomitant decline in CAMP-phosphodiesterase activity. It may thus be 
inferred that the increase in cAMP is as a result of decreased cAMP-phosphodiesterase 
activity. 
The above results may have been predictable as cAMP-phosphodiesterase is an enzyme reliant 
on calmodulin for its activation (Haiech et al., 1981). Thus, the blocking of calmodulin's 
calcium binding sites could result in the absence of active calmodulin. This would result in 
the absence of an active cAMP-phosphodiesterase, producing an accumulation of cAMP. 
However, according to Cheung (1982), adenylate cyclase is also believed to be reliant on 
calmodulin for its activation, but the accumulation of cAMP in the presence of R24571 
suggests that cAMP-phosphodiesterase is more reliant on calmodulin than is adenylate cyclase 
for its activity. 
The relevance of the above studies with respect to NAT activity are found at the adenylate 
cyclase and cAMP-phosphodiesterase level. The activity of these enzymes regulate both 
cAMP and 5' -AMP levels which, have been shown to be important for NAT synthesis (Klein 
et al., 1987; Reiter, 1991) and NAT stimulation (§ 5.2) respectively. Thus, any factor 
affecting adenylate cyclase and cAMP-phosphodiesterase activity would indirectly affect NAT 
activity. 
TABLE 6.2 The effect of R24571 on daytime isoproterenol-stimulated pineal indoleamine 
metabolism (means + SEM; n = 5). 
DPM recovered as: 
MEL NAS MAOP Total Counts 
Control 20831 1 6442 36572 40299 
+ 384 + 147 
R24571 1 185 860 50095 52 139 
+ 108 + 137 
MEL = melatonin,· NAS = N-acetylserotonin; MAOP = monoamine oxidase products. 
1 as compared with the R24571 group, p < 0.05, Student's t test 
2 as compared with the R24571 group, p < 0.025, Student's t test. 
..... g 
161 
--
1800 ....................... 
e 
* ::1 • .-1 
'0 Q) 
e 1500 
r-f 
::1. 
0 
r-f 
........ 1200 a 
'0 
s:: 
• .-1 900 ................... s:: 
0 
.j.J 
0 
~ 
Q) 
m 600 ................... 
r-f 
>t 
.j.J 
Q) 
U 
III 300 I 
~ 
0 
Control R24571 
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levels (means ± SEM, n = 5). 
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6.5 Conclusion 
Pineal gland homogenates treated with EGTA showed a marked increase in NAT activity. 
The opposite was observed in homogenates treated with relatively high concentrations of 
calcium, suggesting that calcium inhibits NAT activity. 
Organ culture studies further support the above in that pineal indoleamine metabolism was 
markedly reduced in the presence of the calcium ionophore A23187 (§ 6.3.4). It can be said 
that the reduction in indoleamine metabolism is as a result of a reduction in pineal enzyme 
activity. 
The enzymes adenylate cyclase and cAMP-phosphodiesterase are both believed to be reliant 
on a calcium binding protein, calmodulin, for their activation (Haiech et al., 1981; Cheung, 
1982). Organ culture studies in the presence ofa calmodulin antagonist, R24571, revealed that 
it reduces indo1eamine metabolism (§ 6.4.3). This could be ascribed to a decrease in the 
availability of the products of adenylate cyclase and cAMP-phosphodiesterase action i.e. 
cAMP and 5'-AMP. This is supported by the findings that in the presence of R24571, cAMP 
levels increased while cAMP-phosphodiesterase activity was found to decrease. These results 
support earlier work which suggests that 5'-AMP rather than cAMP is important for sustained 
pineal enzyme activity and in particular N-acetyltransferase activity (§ 5.2.4). 
The results presented above pose an interesting problem in that the chelation of calcium from 
pineal gland homogenates enhances NAT activity while the addition of calcium produces the 
opposite effect, pointing to an inhibitory function for calcium with respect to NAT. 
However, it is still unclear whether calcium acts directly on NAT or through a calcium 
dependent NAT inhibitory compound. 
Calcium at specific concentrations, however, is required for the activation of calmodulin-
linked enzymes, such as cAMP-phosphodiesterase. The activity of cAMP-phosphodiesterase 
has been linked through its product of metabolism, 5'-AMP, to NAT activity. 
It thus appears that calcium may playa multi-functional role within the pineal, one where it 
could act directly on NAT through a NAT inhibitory compound, and another where it could 
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act through the {3-adrenergic receptor and associated enzymes i. e. adenylate cyclase and 
cAMP-phosphodiesterase. 
7.1 Chapter I 
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CHAPTER VII 
SUMMARY 
A general review of the pineal including its discovery, location, anatomy and biochemistry 
is presented together with a more detailed review of the action, function and regulation of 
serotonin N-acetyltransferase. 
7.2 Chapter n 
A detailed explanation of the different investigative techniques used in this study is presented 
within this chapter. 
7.3 Chapter m 
This chapter deals with two investigations, namely: 
a 24 hour time proflle of tryptophan metabolism by nor-adrenaline stimulated pineal 
glands in organ culture, and 
the comparison of tryptophan and serotonin metabolism by pineal glands in organ 
culture. 
The results obtained from the tryptophan proflle resemble those published by Banoo et al. 
(1987) who used serotonin as the precursor. In both investigations, N-acetylserotonin and 
melatonin were found to be the major metabolites of metabolism. The differences between 
the two experiments are found at the levels of NAS and melatonin synthesised. In the 
tryptophan proflle, NAS levels were found to be significantly higher than melatonin levels, 
whereas in the experiments of Banoo et al. (1987) the opposite was found. The characteristic 
sharp rise in metabolite levels during the first few hours of metabolism found in the serotonin 
proflle of Banoo's et al. (1987) was absent in the tryptophan proflle. 
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The comparison of tryptophan and serotonin metabolism in pineal organ culture experiments 
showed that serotonin is more readily metabolised to melatonin and N-acetylserotonin than 
tryptophan. This is probably due to serotonin entering the metabolic pathway at a later stage 
(i.e. lower down in the metabolic pathway). Thus serotonin has to undergo fewer enzymatic 
reactions than tryptophan to reach NAS and melatonin. 
These fmdings further support the use of serotonin as the precursor in rat pineal organ culture 
studies. 
7.4 Chapter IV 
The role of S-adenosylmethionine (SAM) within the pineal gland has thus far been restricted 
to transmethylation reactions. The most important of these reactions is the methylation of N-
acetylserotonin to melatonin through the activity of hydroxyindole-O-methyltransferase 
(HIOMT). A recent report shows that SAM potentiates cAMP levels in stimulated brain 
slices (Zhong et al., 1990). 
The results of similar investigations on the pineal reveal that SAM exerts no significant effect 
on both indoleamine metabolism and NAT activity (§ 4.2 and 4.3). However, cAMP studies 
reveals that SAM inhibits the isoproterenol-induced rise of these levels (§ 4.4). The 
importance of cAMP for the synthesis and activation of NAT are well documented. Thus, 
SAM may exert a regulatory role on NAT through cAMP. This speculation, however, needs 
further investigation. 
7.5 Chapter V 
Adenosine nucleotide studies revealed that 5' -AMP further induced both dark and 
isoproterenol-stimulated NAT activity. However, an increase in cAMP levels brought about 
by the pharmacological inhibition of cAMP-phosphodiesterase resulted in a decline in NAT 
activity. These results suggest that 5'-AMP could playa role in NAT regulation. 
Further studies involving A TP demonstrated that A TP reduced pineal indoleamine 
metabolism. Whether this reduction in indoleamine metabolism was related to NAT activity 
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is at present unclear, as NAT studies revealed no statistically significant reduction in NAT 
activity in the presence of A TP. The interaction between adenosine nucleotides with respect 
to pineal regulation was also investigated. This investigation showed that pineal activity may 
be regulated via a nucleotide concentration balance. A shift in the balance could act as a 
"switch" to "turn on or off" cellular reactions, thereby regulating pineal activity. 
7.6 Chapter VI 
The calcium signal has emerged as an important component of the intracellular regulation of 
the pineal gland. Calcification of the gland with increasing age was thought to slow pineal 
function (Allen et aZ., 1981). More recently, calcium has been found to playa crucial role 
in the adrenergic regulation of the gland (Brown et aZ., 1989). 
Recently, studies involving the chelating agent EGTA demonstrated its ability to protect NAT 
from inactivation in pineal gland homogenates (Rodriguez-Cabello et aZ., 1990a). The results 
of the present study support the above and further show that EGTA promotes NAT activity. 
However, pineal homogenates treated with calcium resulted in a marked decrease in NAT 
activity. This suggests that calcium actively inhibits NAT activity. 
The results of the EGT A and calcium studies are further supported by the studies using 
A23187, a calcium ionophore. These studies showed that A23187 reduces pineal indoleamine 
metabolism. This reduction in metabolism is thought to be caused via a reduction in pineal 
metabolic activity. However, this has not been confirmed. 
Studies of the effect of the calmodulin antagonist R24571 on cAMP, cAMP-phosphodiesterase 
and organ culture experiments produced markedly different results. R24571 was found to 
increase pineal cAMP levels via a reduction in cAMP-phosphodiesterase activity. 
Notwithstanding R24571 's increase of cAMP levels, pineal indoleamine metabolism is reduced 
in the presence of R24571. The results further support the view expressed in Chapter V which 
suggests that 5'-AMP rather than cAMP is important for sustained NAT activity. 
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CHAPTER vm 
CONCLUSION 
The synthesis of the pineal hormone melatonin from serotonin is regulated by the rate-limiting 
enzyme serotonin N-acetyltransferase (NAT) (Klein et aZ., 1978). NAT shows a diurnal 
rhythm in its activity, with highest activity occurring during the night. The exposure of 
animals to light at night results in the rapid inactivation of NAT (Klein and Weller, 1972; 
Deguchi and Axelrod, 1972b). The mechanism for this rapid inactivation of NAT remains 
unclear, due mainly to the inability of the enzyme to be purified without losing its activity. 
Numerous studies have shown that NAT is activated via the pineal ,8-adrenergic receptor 
(Klein and Weller, 1970; Deguchi and Axelrod, 1972a). The activation is mediated by the 
intracellular second messenger cAMP. The levels of cAMP are crucial for the induction of 
NAT. However, cAMP levels return to normal cellular levels within 30 minutes of ,8-
receptor stimulation (Deguchi, 1973), suggesting that cAMP is not involved in the sustained 
activation of NAT. 
Investigators have repeatedly shown pineal cellular components, such as acetyl coenzyme A, 
nucleotide triphosphates and pyrophosphates, to protect NAT from inactivation during periods 
of high enzyme activity (Binkley et ai., 1976; Namboodiri et aZ., 1979). The validity of 
these results is questioned when it is considered that the concentrations of the cellular 
components tested were far greater than physiological concentrations. 
The results of the present study reveal that 5' -AMP activates NAT activity while ATP 
appears to reduce NAT activity. These results suggest that different nucleotides exert 
different, and possibly opposing, effects on NAT activity. Furthermore, adenosine nucleotide 
levels were found to change during different functional states of the gland, further supporting 
the view that changes in adenosine nucleotide levels result in altered NAT activity. 
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The role of calcium as a component of intracellular regulation and, more importantly, its role 
in the activation of adenylate cyclase and cAMP-phosphodiesterase, the enzymes involved in 
the regulation of nucleotide levels, places it in an important position with respect to NAT. 
Calcium appears to exert a two-fold effect on NAT. The first appears to be a direct effect 
on NAT activity, either through a calcium-dependent NAT inhibitory compound (Chan and 
Ebadi, 1981; Khoory and Schloot, 1986; Lerchl et al., 1991) or through direct interaction 
with the enzyme. This was deduced from experiments which showed NAT activity to 
decrease in the presence of calcium, while the opposite was observed when calcium was 
chelated by EGTA. 
The second effect appears to be an indirect effect through the enzymes adenylate cyclase and 
cAMP-phosphodiesterase. The activity of these enzymes is regulated via a calcium binding 
protein, calmodulin (Cheung, 1982). Thus, any factor affecting calcium influx into the 
pinealocyte would affect the activity of adenylate cyclase and cAMP-phosphodiesterase, 
thereby affecting nucleotide levels. This in tum would affect NAT activity. 
The results presented above lead to speculations on a possible regulatory mechanism for 
NAT. 
During the night, large quantities of nor-adrenaline are released from the sympathetic nerve 
endings innervating the pineal gland (Brownstein and Axelrod, 1974). The nor-adrenaline 
binds to the p-adrenergic receptors on the pinea10cyte cell surface and induces the activity of 
both adenylate cyclase and cAMP-phosphodiesterase (Deguchi, 1973). The induction of the 
above enzymes is also regulated by calmodulin (Cheung, 1982) through the availability of 
calcium. cxI-Receptor-linked calcium channels have been shown to open in the presence of 
nor-adrenaline to allow the influx of calcium (Sugden and Klein, 1988). 
The activation of adenylate cyclase produces a short-term peak in cAMP levels with a 
concomitant decrease in A TP levels. The elevated cAMP level induces protein synthesis with 
the result that de novo NAT is synthesised (Morrissey and Lovenberg, 1978; Romero et ai., 
1978). The metabolism of cAMP to 5' -AMP by cAMP-phosphodiesterase renders large 
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quantities of 5 ' -AMP available for the activation of NAT. The removal of 5' -AMP from the 
system by re-phosphorylation to ADP and A TP could explain the decrease in NAT activity. 
Thus, the phenomenon of NAT inactivation when animals are exposed to light at night may 
be explained as follows: 
light striking the retina of the eye produces an effect on the sympathetic neurons, 
causing the cessation of nor-adrenaline release at the nerve endings innervating the 
pineal. The absence of neurotransmitter at the fj-receptor results in an altered calcium 
influx which in turn affects adenylate cyclase and cAMP-phosphodiesterase activity. 
A decrease in the above enzymes' activities produces a depletion of cAMP and 5' -
AMP with a concomitant increase in ATP through phosphorylation of already 
synthesised 5' -AMP. This results in the inactivation of NAT. 
Thus, a "see-saw" between the levels of ATP, ADP, cAMP and 5' -AMP may be responsible 
for the regulation of NAT, and any external factors affecting the levels of the nucleotides 
indirectly affect NAT activity. 
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